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ABSTRACT
UNRAVELING THE β CELL TRANSLATOME: ELUCIDATION OF AN ERK/HNRNPK/JUND AXIS
AUSTIN L. GOOD
DORIS A. STOFFERS, M.D., Ph.D.
In type 2 diabetes, oxidative stress contributes to the dysfunction and loss of pancreatic β cells. A
highly conserved feature of the cellular response to stress is the regulation of mRNA translation,
however, the mechanisms underlying this process in β cells are not fully understood. Here we
use TRAP-seq to examine changes in the ribosome occupancy of mRNAs during conditions
associated with β cell dysfunction, leading us to identify a cohort of translationally regulated
genes with 3’UTR enrichment of a cytosine-rich motif. Of particular interest was the gene
encoding JUND, a transcription factor with anti-oxidant functions in other cell types but whose
role in β cells is unknown. Interestingly, JUND is translationally upregulated in islets exposed to
high glucose and free fatty acid levels, and depletion of JUND in β cells reduces oxidative stress
and apoptosis caused by these conditions. Transcriptome assessment demonstrates that JUND
regulates a cohort of genes that are commonly dysregulated during β cell dysfunction, including
pro-oxidant and pro-inflammatory genes, consistent with this factor enhancing, rather than
reducing, oxidative stress levels in β cells. Further, hnRNPK, an RNA binding protein with
specificity for cytosine-rich stretches, binds to the mRNA encoding JUND and is required for its
post-transcriptional upregulation during metabolic stress. Although the absolute levels of hnRNPK
do not change, there is a significant increase in hnRNPK phosphorylation during glucolipotoxicity.
Importantly, this hnRNPK/JUND axis is activated in islets from diabetic db/db mice and in human
islets exposed to metabolic stress. Finally, a series of mechanistic studies indicate that hnRNPK
post-transcriptionally regulates JUND in a MEK/ERK- and DDX3X-dependent manner. Thus, a
translation-centric approach uncovered hnRNPK and JUND as stress-responsive factors in β
cells that contribute to redox imbalance and apoptosis during pathophysiologically relevant stress.
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CHAPTER 1: INTRODUCTION
1.1 Paradigms of β cell demise in type 2 diabetes
By 2030, it is predicted that 439 million people across the world, or 7.7% of the
total adult population, will have diabetes (Shaw et al., 2010). The peril posed by
this global escalation in type 2 diabetes (T2D) prevalence is manifold. First, this
disease can have debilitating consequences for patients including blindness,
amputations, and kidney disease. Additionally, the treatment of patients with
diabetes accounted for at least 1 in 8 US health care dollars in 2017 (American
Diabetes Association, 2018). Therefore, the identification of new treatment
strategies to combat the rising prevalence of T2D is a critical task for the
biomedical research community.
A key biological determinant of T2D pathogenesis is the functioning of highly
specialized cells that reside within the pancreas known as pancreatic β cells.
These are the only cells in the body capable of producing and secreting the
hormone insulin to regulate blood glucose levels. β cells, along with other
endocrine cell types, are found within clusters of cells known as islets of
Langerhans, or islets for short. During the progression of T2D, insulin resistance
of peripheral tissues, such as the liver, muscle, and adipose, places a growing
burden on pancreatic β cells to produce and secrete more insulin. Eventually, the
demand for insulin surpasses the functional capacity of β cells, leading to
hyperglycemia (Leahy, 2005). Furthermore, this discrepancy worsens as the
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disease progresses due to a decline in the number and in the functioning of β
cells. This outcome, known as β cell failure, leads to severe hyperglycemia and
diabetic complications (Prentki and Nolan, 2006). There are several proposed
mechanisms to explain the development of β cell failure in T2D, including
impaired insulin secretion, β cell apoptosis, and loss of β cell identity, termed
“dedifferentiation” (Figure 1.1) (Kitamura, 2013). However, the relative
contribution of these processes towards T2D pathogenesis is unclear and may
be dependent on the severity of the disease and the genetic makeup of the
individual (Prentki and Nolan, 2006).

Figure 1.1. β cell dysfunction, apoptosis, and loss of cell identity contribute to β failure in
T2D.

1.1.1 Impaired insulin secretion
In response to insulin resistance in obese individuals, β cells can augment insulin
secretion as much as five times that seen in healthy controls despite only a 50%
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increase in β cell mass (Kahn et al., 2006). This indicates that the insulin
secretory capacity of a single β cell is dynamic and can be expanded to
accommodate increased demand. Thus, the ability of β cells to compensate for
insulin resistance is dependent not just on the number of β cells present in the
pancreas, but also on the functional capacity of those cells. Indeed, it has been
suggested that the initial cause of hyperglycemia in T2D is primarily a
consequence of defects in insulin secretion, not a reduction in the number of β
cells (Prentki and Nolan, 2006). For example, there is only a very small reduction
in β cell mass in patients with a 5 year history of T2D, which is unlikely to explain
the presence of hyperglycemia in the absence of defective insulin secretion
(Rahier et al., 2008). Similarly, C57BL/6 mice fed a high fat diet for 8 weeks
develop hyperglycemia, and the severity of the rise in blood glucose levels
correlates with impairments in insulin secretion, but not β cell mass (Peyot et al.,
2010).
This notion of β cell dysfunction caused by conditions associated with T2D is
also supported by experiments performed on cultured islets obtained from mice
or deceased human organ donors. In this ex vivo paradigm, the concentrations of
glucose and free fatty acid levels in the culture media can be increased to mimic
changes that occur in T2D, a model referred to as glucolipotoxicity. Exposure of
either mouse or human islets to these conditions causes defects in glucosestimulated insulin release (Doliba et al., 2017). Together, these findings indicate
that impaired insulin secretion from β cells contributes to the inadequate insulin
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levels in patients with T2D, and is especially central during early stages of the
disease.
1.1.2 β cell apoptosis
Although reductions in β cell mass may be unable to fully explain the rises in
blood glucose levels that occur during early stages of T2D, it is clear that longstanding cases of T2D and severe hyperglycemia are associated with a
significant decline in the number of β cells (Rahier et al., 2008). This distinction is
especially important when considering the likelihood of success for particular
therapeutic interventions. For example, sulfonylureas, which increase insulin
release from β cells, may be inadequate to restore normoglycemia if there is a
significant reduction in β cell mass (Page and Reisman, 2013).
A main cause of reduced β cell mass in T2D is an increase in β cell apoptosis
(Prentki and Nolan, 2006). Examination of pancreatic tissue from autopsies
indicated that individuals with T2D had reduced β cell mass that was associated
with increased rates of β cell apoptosis (Butler et al., 2003). Many studies have
also shown that elevations in glucose and/or free fatty acid levels lead to
increased apoptosis in β cells during ex vivo culturing (Kharroubi et al., 2004;
Robertson et al., 2003; Shimabukuro et al., 1998).
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1.1.3 Loss of β cell identify
Although significant evidence indicates that β cell apoptosis contributes to the
reduction in β cell mass in T2D, it has recently come into question whether cell
death can fully explain this decrease in β cell number. An alternative explanation
has been proposed in which β cells lose their cell identity during the development
of T2D, which entails the acquisition of features normally restricted to progenitor
cells or other endocrine cell types (Accili et al., 2016; Dor and Glaser, 2013). This
model has been considered plausible partly because there is known to be a high
degree of cellular plasticity amongst endocrine cells of the pancreas (Puri et al.,
2015). For example, after near complete destruction of β cells in mice, α cells
can convert into β cells to regenerate this population (Thorel et al., 2010).
This concept of cellular plasticity was first applied to β cell failure based on the
observation that β cells lose markers of mature β cells and acquire markers of
progenitor cells in mice with genetic deletion of the transcription factor FOXO1 or
in murine models of diabetes (Talchai et al., 2012). The relevance of these
findings to human β cells in T2D, however, is unresolved. A survey of human
diabetic pancreata at autopsy did not find re-expression of NGN3, a marker of
endocrine progenitor cells shown to be increased in mouse models with β cell
dedifferentiation. However, there were some abnormal findings in this analysis
that could support a loss of β cell identity, including cells with co-expression of
NKX6.1 and glucagon/somatostatin and the misexpression of ALDH1a3, another
5	
  
	
  

progenitor cell marker (Cinti et al., 2015). Therefore, it will be critical to reach a
consensus on the features that define a “dedifferentiated” β cell to properly
assess its relevance for T2D. It will also be important to further clarify the fate of
these cells: have they truly adopted a new cell identity or do they simply
represent dysfunctional β cells? Regardless, the idea that reduced β cell mass in
T2D is not solely caused by apoptosis raises the exciting possibility that this loss
may be reversible.
1.2 β cell stress in T2D
In order to develop new therapeutic strategies to prevent or reverse β cell failure
in T2D, the molecular mechanisms underlying these deleterious processes need
to be elucidated. For example, what signaling pathways in β cells promote the
adoption of an apoptotic fate? What factors control β cell identity and how are
they dysregulated in disease conditions? A common theme that begins to
address these questions is that β cells endure various forms of cellular stress in
the pathogenesis of T2D. In this context, the term “stress” refers to a significant
deviation from a homeostatic set point that causes cellular dysfunction and/or
damage. In particular, an imbalance in redox homeostasis, or oxidative stress,
and an imbalance in protein folding homeostasis, or ER stress, have been
implicated in β cell demise in diabetes.
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1.2.1 Oxidative stress
Reactive oxygen species (ROS) are normal byproducts of cellular respiration,
and the major endogenously produced forms of ROS include hydrogen peroxide,
superoxide, and hydroxyl radical (Lipinski, 2001). When generated at low levels,
ROS can function as critical signaling molecules. An important mechanism for
ROS-mediated signaling involves cysteine residues, which are particularly
susceptible to oxidation by ROS due to unique properties of their thiol group
(Poole, 2015). Cysteine oxidation can cause rearrangements in protein
conformation, leading to changes in function or activation of signaling pathways
(Ray et al., 2012). For example, oxidation of Cys-2991 of the kinase ATM by
hydrogen peroxide increases its activity to promote DNA break repair processes
(Guo et al., 2010). When present at high levels, however, ROS can be very
detrimental to the cell by damaging lipids, proteins, and DNA, and the onset of
ROS-mediated injury is referred to as oxidative stress (Schieber and Chandel,
2014). Lipids within cell membranes are particularly vulnerable to oxidation,
which can severely disrupt the structure and function of lipid membranes
throughout the cell leading to cell death (Rochette et al., 2014).
Oxidative stress is proposed to be a central contributor to β cell failure in T2D.
Islets from patients with T2D show increased levels of 8-hydroxy-2' –
deoxyguanosine, a marker of oxidative damage to DNA (Del Guerra et al., 2005).
Animal models of T2D, such as chronic high fat diet feeding in mice, also display
signs of oxidative damage in β cells (Hatanaka et al., 2017). Furthermore,
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antioxidant treatment (Han et al., 2015) or overexpression of antioxidant genes
(Yagishita et al., 2014) can improve β cell function in models of T2D, suggesting
that oxidative stress is an important determinant of β demise in T2D.
The development and resolution of oxidative stress depends on the balance
between the generation of ROS and the levels of antioxidant enzymes that
detoxify these molecules. Antioxidant genes can be subdivided into three groups
based on their targeted ROS species and mechanisms of action: superoxide
dismutases, peroxidases, and thiol-redox proteins (Gelain et al., 2009).
Antioxidant genes are broadly expressed across tissues due to their essential
role in preventing oxidative stress, but their relative expression levels can vary to
meet the needs of a particular cell type. For example, β cells are thought to be
particularly sensitive to oxidative stress due to low expression levels of
antioxidant genes (Lenzen et al., 1996). This is especially true for the hydrogen
peroxide-inactivating enzymes catalase and glutathione peroxidase, which are
expressed in islets at levels less than 5% of that in the liver (Tiedge et al., 1997).
The effect of ROS production on β cell homeostasis is complex because it is
dependent on both the type and subcellular location of the oxidant (Figure 1.2).
For example, β cells seem particularly vulnerable to cell death caused by
superoxide and hydrogen peroxide but are mostly resistant to the oxidant
peroxynitrite, which is generated by the reaction of superoxide with nitric oxide
(Broniowska et al., 2015). This effect cannot be explained by the potency of
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oxidation as peroxynitrite is a very strong oxidant (Pacher et al., 2007). Thus, the
effect of ROS on β cell viability is partly determined by the types of oxidants
being produced, which is further complicated by the reactivity of these molecules
with each other. Along these lines, treatment of islets with low levels of hydrogen
peroxide, but not other oxidants, has been found to increase insulin secretion (Pi
et al., 2007).
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Figure 1.2. ROS production from various subcellular locations contributes to the onset of
oxidative stress. Adapted from (Kreuz and Fischle, 2016).
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Besides the type of oxidant, the site of ROS production in β cells will also dictate
its impact on apoptosis and can vary depending on the conditions invoking
oxidative stress (Figure 1.2). Under conditions of excess glucose, for example,
increased electron flux through the respiratory chain leads to increased
production of superoxide in mitochondria (Robertson et al., 2003). Mitochondria
contain a distinct set of antioxidant enzymes that detoxify ROS produced in this
setting, such as mitochondrial superoxide dismutase that resides exclusively in
the mitochondrial matrix (Ježek et al., 2012). Thus, the severity of oxidative
stress in mitochondria will largely be determined by the functioning of
mitochondrial, but not cytosolic, antioxidant enzymes. On the other hand, the
presence of excess lipid can cause fatty acid catabolism to shift largely into
peroxisomes, which leads to hydrogen peroxide, rather than superoxide,
generation (Gehrmann et al., 2010). Interestingly, ROS production from
peroxisomes, rather than mitochondria, has been suggested to promote
apoptosis in β cells during glucolipotoxicity (Elsner et al., 2010).
The other major proposed sources of ROS production in β cells are located in the
cytoplasm. Under conditions of excess glucose, for example, glucose metabolites
can be shunted towards atypical pathways including the hexosamine pathway,
which has been suggested to increase hydrogen peroxide levels in β cells
(Kaneto et al., 2001). Additionally, members of the NADPH oxidase (NOX) family
can generate cytoplasmic superoxide by directly transferring electrons from
NADPH to oxygen (Maghzal et al., 2012). These enzymes are best known for
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their role in innate immunity in which they produce large amounts of superoxide
in neutrophils for release at sites of infection (Nguyen et al., 2017). NOX-1, -2,
and -4 are expressed at low levels in β cells, and their activity may be increased
during exposure to glucotoxicity or pro-inflammatory cytokines (Morgan et al.,
2006; Weaver et al., 2014). Similarly, there are many additional enzymes that
catalyze redox reactions in common biological processes. For example, the
metalloreductase STEAP4 facilitates the movement of electrons from NAPDH to
extracellular iron or copper (Scarl et al., 2017). Under certain conditions,
however, this enzymatic function of STEAP4 may promote oxidative stress in the
cell (Zhou et al., 2013a). Thus, ROS production can also be derived from the
enzymatic activity of pro-oxidant genes. Given the wide range of sources,
subcellular locations, and types of oxidants produced in the cell, it is not
surprising that the pertinent causes of oxidative stress in β cells during T2D are
still uncertain.
Additionally, the upregulation of antioxidant genes to combat oxidative stress
may be a coordinated process in the cell. For example, the transcription factor
NRF2 is a key regulator of antioxidant genes across different cell types (Itoh et
al., 1997). In the absence of oxidative stress, NRF2 is targeted for ubiquitination
by the adaptor protein KEAP1 leading to its proteasomal degradation. Increased
ROS levels, however, inhibit KEAP1 function via cysteine oxidation, and NRF2
levels accumulate in the nucleus to upregulate antioxidant genes (Uruno and
Motohashi, 2011). Interestingly, overexpression of NRF2 in β cells improves
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hyperglycemia in several models of diabetes (Uruno et al., 2013; Yagishita et al.,
2014). Similarly, the transcription factor JUND has also been proposed to reduce
oxidative stress by regulating antioxidant gene expression (Gerald et al., 2004;
Paneni et al., 2013). However, its role in β cell redox homeostasis is unknown.
In all, there is strong evidence linking oxidative stress to β cell dysfunction and
apoptosis. However, there are many potential mechanisms that may contribute to
ROS accumulation during T2D pathogenesis and the relative contribution of
these processes to β cell demise is unclear. Thus, advances in our
understanding of how β cells adapt to environmental conditions associated with
oxidative stress may provide new therapeutic opportunities for T2D.
1.2.2 ER stress
Another instance of homeostasis that is critical for cell viability is the balance
between the abundance of nascent peptides and the protein folding capacity of
the endoplasmic reticulum (ER). If protein synthesis exceeds the folding capacity
of the ER, there will be an accumulation of unfolded proteins, termed ER stress.
Prolonged ER stress can lead to protein aggregation, cellular dysfunction, and
apoptosis (Hetz, 2012). Since a major function of β cells is to synthesize and
process proinsulin polypeptides, the balance between protein synthesis and
folding is particularly important in these cells. In T2D, ER homeostasis is
disrupted when insulin resistance causes the demand for insulin synthesis to
overwhelm the folding capacity of β cells (Evans Molina et al., 2013).
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The response to ER stress consists of a highly conserved set of processes
known as the unfolded protein response (UPR). The presence of unfolded
proteins in the ER activate three distinct branches of the UPR: IRE1α/XBP1,
PERK, and ATF6. Together, these factors activate a cellular program that initially
aims to restore protein folding homeostasis by increasing expression of ER
chaperones and degrading unfolded proteins (Figure 1.3). Chronic activation of
the UPR, however, promotes cell death via pro-apoptotic factors, such as CHOP
(Hetz et al., 2013).
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Figure 1.3. The unfolded protein response (UPR) shapes cellular adaptation to ER stress.
Adapted from (Navid and Colbert, 2017).
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Pancreata from T2D patients show evidence of ER stress in β cells, including
induction of CHOP and dysregulation of the UPR mediators ATF6 and XBP1
(Engin et al., 2014; Huang et al., 2007). Mutations in the gene EIF2AK3, which
encodes PERK, leads to permanent neonatal diabetes due to a reduction in the
number of β cells (Delépine et al., 2000). Furthermore, culturing islets under
glucolipotoxic conditions leads to ER stress, UPR activation, and apoptosis
(Laybutt et al., 2007). On the other hand, genetic deletion of CHOP rescues β
cell survival and function in several mouse models of T2D (Song et al., 2008).
Thus, chronic activation of the UPR occurs in β cells during metabolic stress,
leading to cellular dysfunction and apoptosis.
Beyond the canonical components of the UPR, β cell-specific factors may also
shape the ER stress response to fit the particular needs of this cell type. For
example, the transcription factor PDX1 is required for pancreas organogenesis
and maintenance of cell identity in mature β cells (Gao et al., 2014; Jonsson et
al., 1994; Stoffers et al., 1997a), and specific heterozygous mutations in PDX1
cause monogenic diabetes (Stoffers et al., 1997b). Furthermore, mice with
heterozygous loss of PDX1 have defects in β cell compensation during high fat
feeding, which is associated with increased ER stress and apoptosis in β cells.
PDX1 promotes adaptation to a high fat diet by regulating the expression of
genes involved in ER function and the UPR (Sachdeva et al., 2009). This
indicates that PDX1 enhances β cell resiliency during ER stress by shaping an
adaptive gene regulatory network.
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This example also serves to illustrate a general principle that deserves further
elaboration. The identification of PDX1 as a key regulator of β cell adaptation to
stress implies that a useful approach to better understand the mechanisms
underlying the stress response in β cells is to closely scrutinize the network of
genes that become dysregulated upon depletion of PDX1. This approach holds
promise to advance our understanding of how β cells adapt to stress, how this
adaptation may fail in disease, and what targets may be candidates for
therapeutic intervention.
1.3 Translational regulation and cellular stress
A critical and prominent part of stress responses across cell types is the
regulation of mRNA translation, which allows for rapid changes in gene
expression to restore homeostasis. For example, one component of the UPR is
increased translation of the mRNA encoding ATF4, a transcription factor that
upregulates genes involved in protein folding (Harding et al., 2000; Lu et al.,
2004). Further, genome-wide assessment of ribosome occupancy, a proxy for
translational efficiency, shows a striking reprogramming of translation for
hundreds of genes during ER stress and heat shock (Sidrauski et al., 2015;
Ventoso et al., 2012; Zhou et al., 2015). Since translational regulation may not be
accompanied by changes in mRNA abundance, common approaches such as
RNA-seq will not detect this layer of gene regulation. As such, translational
regulation represents an essential, yet understudied, mechanism of cellular
adaptation during stress.
17	
  
	
  

β cells are highly secretory cells that require tight control of protein synthesis for
proper functioning (Evans Molina et al., 2013; Scheuner et al., 2005). For
example, the acute adaptation to high levels of glucose includes increased
translation of the mRNA encoding proinsulin (Itoh and Okamoto, 1980).
Furthermore, excess translation rates during glucolipotoxicity have been linked to
the onset of ER stress (Hatanaka et al., 2014). However, the mechanisms
underlying translational regulation in β cells during stress conditions are poorly
understood.
1.3.1 Overview of translation initiation
Translation initiation consists of a highly regulated, multi-step process that is
generally considered the rate-limiting step of translation (Parsyan et al., 2011),
although regulation can occur at the level of translation elongation in some
circumstances (Hussey et al., 2011). The process of translation initiation requires
recruitment of the 43S pre-initiation complex (PIC) to the 5’ end of the mRNA,
scanning of the PIC to a start codon, and formation of a competent ribosomal
complex for elongation (Figure 1.2). For most mRNAs, this process is dependent
on the presence of two particular RNA modifications that are added posttranscriptionally: a 7-methylguanylate (m7G) cap at the 5’ end and a stretch of
adenosine monophosphates at the 3’ end (poly(A) tail). Upon export to the
cytoplasm, mRNA is bound at the 5’ cap by the eukaryotic translation initiation
factor 4E (eIF4E), which is part of a heterotrimeric complex called eIF4F that also
includes a scaffold protein eIF4G and an RNA helicase eIF4A. Separately, the
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small ribosomal subunit (40S) is decorated by many additional translation
initiation factors, including eIF2, the initiator tRNA, and the multi-subunit factor
eIF3, and this large complex is collectively called the 43S PIC. Interaction
between eIF4G and eIF3 facilitates the recruitment of the 43S PIC to the mRNA
5’ cap, after which the 43S PIC scans along the mRNA until a start codon is
encountered. This is followed by the assembly of an 80S ribosomal complex,
which requires GTP hydrolysis by eIF2 and recruitment of the 60S ribosomal
subunit (Jackson et al., 2010).

19	
  
	
  

Figure 1.4. Translation initiation is a complex, multi-step process. Adapted from (Parsyan
et al., 2011).
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In addition to the assembly of translation machinery at the 5’ end of mRNAs,
efficient translation also depends upon factors binding to the 3’ end, most
importantly the poly(A)-binding protein (PABP). This factor binds to the poly(A)
tail and eIF4G to facilitate RNA circularization. These interactions are thought to
increase the efficiency of translation by enhancing binding of eIF4F to the 5’ cap
and facilitating the re-initiation of ribosomal subunits at start codons after
termination, termed ribosome recycling (Dever and Green, 2012).
While these steps encompass translation initiation for most mRNAs, certain
properties can alter the requirements for initiation to occur. For example, some
mRNAs contain a highly structured 5’ UTR that inhibits scanning of the PIC. In
this case, efficient translation initiation requires supplementary factors, such as
additional RNA helicases, to unwind the RNA secondary structures and promote
scanning (Marintchev, 2013). Besides providing structural blockades for
translation, RNA secondary structure in 5’ UTRs can also influence the function
of initiation factors. For example, eIF3 generally promotes translation initiation via
recruitment of the PIC, however, certain mRNAs contain 5’ UTR structural
elements that cause eIF3 to act as a translational repressor (Lee et al., 2015).
A useful paradigm for studying atypical modes of translation initiation is the
translation of viral mRNAs. Viruses are completely dependent on the host
translation machinery for their replication and propagation. Counterintuitively,
however, many viruses incapacitate the translation machinery of infected cells to
shut-off translation of host mRNAs. This is achieved by a broad range of
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mechanisms, including expression of a viral protease that cleaves eIF4G
(poliovirus), reducing eIF4E expression levels (enterovirus 71), sequestration of
eIF3 via viral proteins (measles virus), and cleavage of PABP by viral proteases
(retroviruses) (Walsh et al., 2013). While this impairment of translation cripples
the host’s defense mechanisms, it also presents the conundrum of how to
translate viral mRNAs. For this reason, viruses have evolved various
mechanisms to initiate translation using host machinery in a cap-independent
manner. One prominent example of this phenomenon is the presence of an
internal ribosomal entry site (IRES) near the 5’ end of viral mRNAs. IRESs are
highly structured RNA elements that recruit the 40S ribosomal subunit to mRNA
in a cap-independent manner. There are several different classes of IRESs, each
of which require a distinct subset of trans-acting factors, including translation
initiation factors, RNA binding proteins, and viral proteins, for efficient translation
(Sweeney et al., 2013). For example, the IRES in poliovirus mRNA requires
eIF4F and eIF3 for recruitment of the 40S ribosomal subunit, whereas hepatitis C
virus mRNA requires eIF3 but not eIF4F and cricket paralysis virus mRNA does
not require either of these factors (Komar et al., 2012). Importantly, many of
these mechanisms for alternative initiation are thought to be pirated from their
hosts, meaning that certain host mRNAs also employ these mechanisms under
certain conditions. For example, the mRNA encoding c-MYC contains an IRES
element, which confers cap-independent translation that is stimulated by the
RNA binding protein hnRNPK (Evans et al., 2003). The broad range of
mechanisms employed by viruses for translation initiation raises the intriguing
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possibility that we have only just begun to understand the usage of these
processes for translational regulation of endogenous mRNAs.
Indeed, the multi-faceted process of translation initiation is regulated at various
steps during stress conditions, allowing for the tight control of both global
translation rates and selective translation of key mRNAs. Below, we outline
several examples of translational regulation during stress that influence cellular
homeostasis.
1.3.2 Regulation of global translation rates
Protein synthesis consumes a significant amount of cellular energy, thus
dampening global translation rates during stress conserves cellular resources
and promotes cell survival (Evans Molina et al., 2013). For example, the UPR
influences global translation rates by several mechanisms. First, activated PERK
phosphorylates eIF2α, which reduces its function and suppresses translation
initiation (Hetz, 2012). This regulation is critical for β cell adaptation to stress in
vivo as mutation of the phosphorylated site of eIF2α in mice led to the
accumulation of unfolded proteins and defective insulin secretion during high fat
feeding (Scheuner et al., 2005). Second, 4E-BP1, which reduces global
translation rates by sequestering eIF4E, is upregulated by ATF4 and ATF5
during ER stress (Juliana et al., 2017; Pause et al., 1994; Spriggs et al., 2010).
Loss of 4E-BP1 in β cells leads to increased apoptosis during conditions of ER
stress due to unchecked translation rates (Yamaguchi et al., 2008). Thus,
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dampening translation is critical for the adaptation of β cells to ER stress
because it reduces the protein folding burden and conserves cellular resources.
While we have highlighted the importance of regulating general protein synthesis
during stress, it should be noted that control of this process is also essential for
cell growth. For example, the mTOR signaling pathway integrates growth signals
with downstream processes required for proliferation, including cap-dependent
translation. Specifically, mTOR increases global translation rates by activation of
the ribosomal protein S6K and inactivation of 4E-BPs, thereby increasing the
availability of eIF4E for translation initiation (Mamane et al., 2006). This increase
in translation allows for the synthesis of proteins to accommodate the expansion
of cell size and the formation of new cells.	
  
1.3.3 Selective regulation of translation
While the regulation of global translation rates promotes recovery from stress by
conserving cellular resources and reducing the protein folding burden, the
selective translation of mRNAs impacts cellular homeostasis indirectly by altering
the gene expression program of the cell. This mechanism for altering gene
expression may be advantageous over transcriptional regulation because it
occurs downstream of transcription and thus can very quickly alter protein levels
(Sidrauski et al., 2015).
In order for selective translation to occur, this directive must be encoded in the
mRNA, which can be achieved by three general mechanisms. First, selective
24	
  
	
  

translation can be governed by the presence of regulatory sequences in the
mRNA that are bound by sequence-specific factors that regulate translation, such
as RNA binding proteins (RBPs) or microRNAs. Second, mRNAs can be
translationally regulated based on the presence of RNA secondary structures
rather than primary sequence elements. Lastly, upstream open reading frames
(uORFs) in 5’UTRs can affect the re-assembly of ribosome complexes on
downstream canonical initiation codons (Jackson et al., 2010). The translational
induction of genes containing uORFs, such as ATF4, ATF5, and CHOP, has
been well characterized to be a consequence of eIF2α phosphorylation by PERK
during ER stress (Somers et al., 2013). However, the extent to which primary
sequence or secondary structural elements shape translational regulation during
stress is less known.
Importantly, these regulatory elements may be present in a cohort of genes that
are functionally related, allowing for the coordinated re-shaping of gene
expression towards a specific purpose. This notion forms the basis of the “RNAoperon” theory, which postulates that trans-acting factors, such as RBPs, may
integrate environmental signals with the post-transcriptional regulation of specific
genes that share a common function (Keene, 2007). This model is especially
intriguing in the context of β cell adaptation to pathophysiologically-relevant
conditions; however, the role of RBPs in shaping the β cell gene expression
program in response to external cues is largely unknown.
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RBPs regulate all aspects of post-transcriptional RNA processing, including
splicing, stability, localization, and translation. In fact, mRNAs are generally
bound by a broad array of RBPs throughout their life cycle, positioning these
factors to rapidly integrate cellular signals with changes in gene expression. The
target specificity of an RBP is directed by its RNA-binding domain, which
interacts with RNA in a sequence- and structure-dependent manner (Lukong et
al., 2008). It is estimated that there are anywhere between 500 and 1500 RBPs
in humans containing more than 40 different types of RNA-binding domains,
underscoring the broad importance of these proteins in biological processes
(Gerstberger et al., 2014). For example, the most common RNA-binding domain,
the RNA recognition motif (RRM), is found in more than half of all RBPs and is a
highly plastic domain that can bind RNA with both high-affinity and highspecificity (Maris et al., 2005).
RBP-mediated post-transcriptional regulation is exemplified in β cells by the role
of the polypyrimidine tract-binding protein (PTB) in adaptation to hyperglycemia.
Part of the β cell response to high glucose levels is the upregulation of genes
involved in insulin processing and secretory granule biogenesis, and many of
these genes were found to be upregulated at the level of mRNA stability, not
transcription (Knoch et al., 2004; Martin et al., 1994). Interestingly, loss of PTB
blocked the post-transcriptional induction of these genes and significantly
reduced insulin granule biogenesis (Knoch et al., 2004). Thus, by coordinating
the post-transcriptional regulation of genes with a common function, constituting
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an RNA operon, PTB augments β cell insulin secretory capacity during high
glucose conditions. It is enticing to speculate that this example is just the tip of
the iceberg for RBPs mediating adaptive mechanisms in β cell. Therefore, a
systematic evaluation of post-transcriptional changes in β cells, and the RBPs
governing these changes, warrants close examination.
1.3.4 Translational regulation mediated by the PCBPs
The poly(C)-binding protein (PCBP) family consists of five members: hnRNPK
and PCBP1-4. These factors all contain three K homology (KH) domains, which
provide the specific targeting of cytosine-rich sequences (Makeyev and
Liebhaber, 2002). The PCBP members are highly multifunctional RBPs involved
in many aspects of gene regulation, including transcription, splicing, alternative
polyadenylation, mRNA stability, and translation (Bomsztyk et al., 2004; Ji et al.,
2013; 2016; Makeyev and Liebhaber, 2002; Ostareck-Lederer et al., 2002;
Waggoner et al., 2009). Their impact on gene expression is likely determined by
a host of factors, including their subcellular localization, post-translational
modifications, and interacting co-factors (Bomsztyk et al., 2004). The members
hnRNPK and PCBP1-2 are ubiquitously expressed and play critical roles in a
range of cellular processes, some of which are cell type-specific (Makeyev and
Liebhaber, 2002). For example, PCBP1-2 promote the differentiation of functional
erythrocytes by binding to the 3’UTR of α-globin mRNA and significantly
stabilizing this transcript (Kiledjian et al., 1995). These factors are also regulated
extensively by post-translational modifications, especially phosphorylation. This
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allows for the function of these proteins, including their impact on mRNA
translation, to be modulated downstream of various signaling pathways
(Chaudhury et al., 2010a).
The first example of translational regulation mediated by the PCBPs was the
translational silencing of the mRNA encoding erythroid 15-lipoxygenase. This
enzyme is responsible for the breakdown of phospholipids during late stages of
erythrocyte maturation and must be silenced at earlier stages. Interestingly, 15lipoxygenase mRNA is abundantly expressed throughout the stages of
differentiation. Rather, its temporally restricted expression pattern is entirely
dependent on translational silencing via a large cytosine-rich stretch in the 3’
UTR. hnRNPK and PCBP1 were identified as the factors binding to this
regulatory element and inhibiting translation by preventing 60S ribosomal subunit
joining (Ostareck et al., 2001; 1997). Curiously, translation of the mRNA
encoding c-Src kinase is also translationally silenced in erythroid progenitor cells
by hnRNPK, but not PCBP1 (Naarmann et al., 2008). Thus, three different
mRNAs expressed in erythroid cells, 15-lipoxygenase, c-Src, and α-globin, are
post-transcriptionally regulated by members of the PCBP family via binding to Crich sequences in the 3’UTR. Despite these similarities, the regulation of these
mRNAs are distinct based on the mode of regulation (RNA stability or translation)
and on the PCBP family members imparting this regulation. It is unclear how
these RBPs provide distinct functions depending on their target mRNA but likely
depends on the presence of additional cofactors.
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Along these lines, the translational regulation provided by PCBP family members
can be either translational enhancement or repression. Like 15-lipoxygenase and
c-Src, hnRNPK represses translation of the mRNAs encoding transforming
growth factor-β-activated kinase 1 (TAK1) and the androgen receptor (Liepelt et
al., 2014; Mukhopadhyay et al., 2009). On the other hand, hnRNPK has been
implicated in the translational enhancement of the mRNAs encoding Bruton’s
tyrosine kinase (p65BTK), myelin basic protein (MBP), neurofilament medium
(NF-M), vascular endothelial growth factor (VEGF), and c-MYC (Evans et al.,
2003; Grassilli et al., 2016; Hutchins and Szaro, 2013; Laursen et al., 2011;
Sataranatarajan et al., 2008). PCBP1 and PCBP2 have also been found to either
stimulate or repress translation depending on the target mRNA (Chaudhury et al.,
2010b; Eiring et al., 2010; Evans et al., 2003; Laursen et al., 2011; Wang et al.,
2010).
Furthermore, translational regulation mediated by the PCBPs can be modified by
phosphorylation of these RBPs in response to external cues. For example, the
mRNAs encoding DAB2 and ILEI, which are critical for epithelial-mesenchymal
transdifferentiation (EMT), are translationally repressed by PCBP1 via 3’UTR
binding. Treatment of cells with TGF-β, however, leads to PCBP1
phosphorylation, reduced PCBP1 binding to the 3’UTRs, and enhanced
translation of DAB2 and ILEI to promote EMT (Chaudhury et al., 2010b).
Similarly, phosphorylation of hnRNPK can lead to changes in its subcellular
localization and RNA binding affinity, both of which can impact target mRNA
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translation (Habelhah et al., 2001; Ostareck-Lederer et al., 2002; Ostrowski et al.,
2001). hnRNPK likely impacts translation by interacting with cofactors that either
repress or promote translation initiation (Bomsztyk et al., 2004), and these
interactions may also be modulated by phosphorylation. For example,
phosphorylation of hnRNPK by JNK leads to enhanced translation of cytoskeletal
RNAs required for axon outgrowth in developing neurons of Xenopus laevis. This
effect on hnRNPK was not attributable to a change in its subcellular localization
nor a change in its RNA binding affinity. Instead, it was suggested that JNK
signaling altered the interaction of hnRNPK with translation machinery, however,
the precise mechanisms by which this occurred were not elucidated (Hutchins
and Szaro, 2013).
In the work described herein, we investigate translational regulation and the
mechanisms controlling these processes in the context of β cell dysfunction. We
explore the role of the PCBPs in β cells, including their post-transcriptional
control of gene expression during stress conditions. Together, these studies aim
to uncover novel mechanisms governing β cell adaptation to stress that may
pertain to the pathogenesis of T2D.
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CHAPTER 2: TRAP-SEQ UNCOVERS POST-TRANSCRIPTIONAL
REGULATION MEDIATED BY THE PCBPS IN β CELLS
2.1 Summary
Translational regulation is a highly conserved and critical component of stress
responses, however, the mechanisms underlying this process in β cells are not
fully understood. Here we used TRAP-seq to uncover a subset of genes with
changes in ribosome occupancy in Min6 cells with PDX1 deficiency, including
genes encoding the transcription factors NKX2-2 and JUND. De novo motif
analysis identified enrichment of a poly(C) motif in the 3’UTRs of genes with
increased ribosome occupancy, suggesting a functional role for the poly(C)binding protein (PCBP) family of RNA binding proteins in β cells. The PCBP
members PCBP1, PCBP2, and hnRNPK all bound to the mRNAs encoding
NKX2-2 and JUND, and loss of PCBP1/2 led to a post-transcriptional reduction in
these genes. Additionally, glucose-stimulated insulin secretion was impaired in
Min6 cells with depletion of PCBP1/2 or hnRNPK, suggesting that these factors
are functionally important in β cells.
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2.2 Introduction
The specialization of cells is bestowed largely by the distinct catalog of proteins
present in a given cell type, yet all cells of an organism contain the same genetic
information. Thus, mechanisms to selectively decode genetic information are
crucial for the functional specificity of cells. Advances in our understanding of the
cellular controls that decode genetic information, and how they become
dysfunctional in disease states, will be a central step towards unlocking the next
generation of medical therapeutics. For example, we are on the cusp of treating
an array of diseases with cell-based therapies. The advancement and expansion
of these approaches, however, will rely on a better understanding of the genetic
controls shaping cell identity and how environmental cues impact these
processes.
The decoding of genetic information for the synthesis of proteins is dynamic and
requires a full cycle of events to take place: transcription of DNA into RNA,
processing RNA to mRNA, translation of mRNA to protein, and degradation of
mRNA/protein. Importantly, all of these steps represent potential regulatory
points to shape the gene expression profile of a cell. Due to rapid advances in
the depth and accuracy of DNA sequencing technologies, however, it is
commonplace to use mRNA abundance as a proxy for the functional output of
genetic information. This approach is certainly useful when focusing on
transcriptional regulators, but it will miss regulation at the level of mRNA
translation or protein degradation. This has led to a bias in our understanding of
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gene regulation, including in β cells: the factors shaping transcriptional regulation
are much better understood than those regulating mRNA translation.
Translational regulation is particularly important in the context of dynamic shifts in
gene expression required for adaptation to environmental conditions, external
stimuli, or stress conditions. Since translation is downstream of transcription, a
cell can respond to a stimulus more quickly by increasing translation of an mRNA
compared to increasing its transcription. The regulation of translation can be
grouped into two broad categories: regulation of global translation rates and
selective translational regulation of specific mRNAs. Tight control of global
translation rates is critical for cells because protein synthesis is associated with
high cellular energy consumption. A common mechanism for this type of
translational regulation is post-translational modification of a component of the
translation machinery. For example, mTOR signaling integrates growth signals
with translation rates by phosphorylating eukaryotic translation initiation factor
4E-binding protein 1 (4E-BP1) and ribosomal protein S6K1/2 (Mamane et al.,
2006).
Selective regulation of translation, on the other hand, allows for rapid changes in
gene regulatory networks that shape the cellular response to various conditions.
This mechanism for translational regulation seems to be particularly important in
the context of cellular stress responses. For example, during ER stress there is
increased translation of select mRNAs with upstream open reading frames
(uORFs), such as ATF4. This response promotes restoration of ER homeostasis
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by increasing the protein folding capacity of the ER (Harding et al., 2000).
Similarly, inhibition of cap-dependent translation occurs under various stress
conditions, such as during infection of cells with picornaviruses due to cleavage
of eIF4G by a viral protease or during ER stress due to upregulation of 4E-BP1.
These alterations of translational machinery promote the cap-independent
translation of specific mRNAs containing internal ribosomal entry sites (IRESs)
while global translation rates are suppressed (Spriggs et al., 2008). For example,
the transcript encoding the chaperone BiP was the first eukaryotic mRNA found
to contain an IRES, which allows for the translation of this factor during ER stress
to enhance cellular protein folding capacity (Macejak and Sarnow, 1991).
Translation rates of mRNAs can be directly measured by pulse labeling followed
by mass spectrometry, however, this approach is technically challenging and
requires large amounts of input material. Accordingly, alternatives to this method
have been developed that determine the relative density of ribosomes bound to
mRNAs, which can be assessed on a genome-wide scale with RNA-seq (Kapeli
and Yeo, 2012). The use of these approaches to assess translational regulation,
however, relies on several assumptions because they are indirect measurements
of translation. Nevertheless, an understanding of these assumptions and careful
scrutiny of the obtained results will allow for the successful implementation of
these methodologies. For example, an increase in ribosome binding to an mRNA
cannot distinguish between actively translating or stalled ribosomes. As such, an
observed change in mRNA ribosome occupancy should be confirmed to cause
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an appropriate change in protein level by western blot analysis. Additionally,
ribosome run-off assays can be used to rule out the presence of stalled
ribosomes (Pelechano et al., 2015). It should also be noted that these
methodologies are useful for detecting changes in translation initiation, which is
thought to be the major regulatory step of translation, but not for changes in
translation elongation or termination. Instead, the study of translational regulation
occurring at the elongation step requires specific methodologies to assess the
kinetics of ribosome run-off (Richter and Coller, 2015).
The first methodology that used changes in ribosome occupancy to assess
translation was polysome profiling. This method separates mRNAs into different
fractions based on the relative abundance of bound ribosomes using sucrose
gradient sedimentation. For example, during ER stress, the mRNA encoding
ATF4 shifts towards greater representation in the polysome fraction compared to
the monosome fraction, which indicates an increase in ribosome binding during
stress (Hatanaka et al., 2014). However, this methodology has several
disadvantages including the requirement for significant starting material and the
inability to distinguish between cell types in a heterogeneous tissue.
Furthermore, this method uses density gradient centrifugation to separate
mRNAs into polysome and monosome populations. This assumes that the main
factor contributing to the density of an mRNA is the number of bound ribosomes.
It is unclear if this assumption is a valid one or if large RNP complexes other than
ribosomes may contribute to mRNA density (Kuersten et al., 2013).
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To circumvent some of these disadvantages, methods that rely on the
immunoprecipitation of tagged ribosomal subunits have also been developed,
such as Translating Ribosome Affinity Purification (TRAP, GFP-tagged RPL10a)
and RiboTag (HA-tagged RPL22) (Heiman et al., 2008; Sanz et al., 2009). In
these methods, comparison of transcript abundance in the immunoprecipitated
RNA fraction to that in total RNA can be used to determine the ribosome
occupancy of mRNAs, an approximation of translational efficiency. By expressing
these transgenes from a cell type-specific promoter, ribosome-bound mRNA can
be purified for a specific subpopulation of cells within a heterogeneous tissue.
Therefore, these approaches are particularly useful when attempting to assess
translational regulation in vivo because most tissues are composed of a complex
mixture of cell types. Also, these methods use a highly specific
immunoprecipitation step to purify ribosomes and their associated mRNAs and
do not rely on the assumption that ribosomes are the main determinant of mRNA
density.
One disadvantage to all of the methodologies mentioned above is that they
involve sequencing of full-length mRNA. For this reason, the positioning of
ribosomes along mRNAs cannot be discerned by these approaches. In contrast,
ribosome profiling, which is the most recent advance in studying translation,
utilizes an RNase digestion step to generate ribosome-protected RNA fragments.
High-throughput sequencing of these footprints can then be used to determine
not only the density of ribosomes binding to an mRNA, but also the location of
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ribosomes along the transcript, including the relative usage of start codons
(Ingolia et al., 2009; 2011). This allows for the study of alternative translation
initiation, which is particularly interesting given that initiation from non-AUG
codons may be a common mechanism to increase protein diversity and can be
regulated under stress conditions (Touriol et al., 2012).
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2.3 Materials and Methods
Cell line culture
Min6 mouse insulinoma cells passage 20-30 were cultured in high glucose
DMEM as described (Claiborn et al., 2010), unless otherwise noted. For siRNAmediated depletion of Pdx1, cells were nucleofected by AMAXA with siRNA for
Pdx1 (Dharmacon L-040402-01) or non-targeting control (Dharmacon D-00181010) and collected 72hrs post-transfection. For lentiviral infections, Min6 cells
were transduced for 6 hours with virus and polybrene (Sigma) at 8ug/mL. Cells
were allowed to recover for 4-5 days before collection or stress treatments.
HEK293T cells were cultured in DMEM containing 25mM glucose.
GFP-RPL10A Min6 stable cell line
The GFP-RPL10A transgene was generated by cloning PCR amplified fragments
for GFP-RPL10A or GFP into the pBABE-puro retroviral vector (Morgenstern and
Land, 1990) digested with SalI. Retrovirus was produced in HEK293T cells and
added to Min6 cells, followed by two rounds of puromycin selection (5 days,
2ug/mL).
Glucose-stimulated insulin secretion in Min6 cells
Min6 cells were seeded in a 12 well plate 3 days prior to GSIS experiment
(~400,000 cells/well). On day of experiment, fresh KRBH buffer (15mM HEPES,
120mM NaCl, 4.7mM KCl, 1.2mM MgSO4, 1.2mM KH2PO4, 20mM NaHCO3,
2mM CaCl2, 0.01% BSA) was prepared and the pH was adjusted to 7.4. Glucose
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was dissolved in KRBH to obtain solutions with glucose concentrations of 2.5mM
(low glucose) and 25mM (high glucose).
Wells were washed with PBS and KRBH (no glucose). 500ul of glucose-free
KRBH was added to each well and plates were incubated for 1 hour at 37C.
Wells were washed once with glucose-free KRBH and 500ul of 2.5mM glucose
KRBH was added to each well, then incubated at 37C for 30 minutes. 100ul of
supernatant was transferred to tubes and placed on ice. The remaining KRBH
was removed from each well and one wash with glucose-free KRBH was
performed. 500ul of 25mM glucose KRBH was added to each well, then
incubated at 37C for 30 minutes. 100ul of supernatant was transferred to tubes
and placed on ice. The remaining KRBH was removed, wells were washed twice
with cold PBS, and cells were harvested with 100ul lysis buffer containing
protease inhibitor. LG and HG supernatant samples were centrifuged at 1500g
for 5 min at 4C. 50ul of supernatant was taken and froze at -20C along with cell
lysates. Insulin levels in LG, HG, and cell lysate samples were measured by
ELISA (ALPCO, 80-INSMSU-E01), as per manufacturer instructions.
RNA isolation and RT-qPCR
For Min6, cells were washed 2X with cold PBS before addition of TRIZOL
(Invitrogen) and RNA was extracted according to manufacturer’s instructions.
RNA was reverse transcribed with random hexamers using High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems). Quantitative PCR (BioRad
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CFX384) was used to measure transcript abundance and normalized to HPRT.
See Table 1 for a list of primer sequences used for these analyses.
Western blot
Proteins were separated by SDS-PAGE and immunoblotted with the following
antibodies: mouse anti-NKX2-2 (Hybridoma Bank, 74.5A5), rabbit anti-JUND
(Santa Cruz, sc-74), rabbit anti-PCBP1 (Liebhaber lab), rabbit anti-PCBP2
(Liebhaber lab), rabbit anti-hnRNPK (Bethyl Laboratories, A300-674A), mouse
anti-Tubulin (Sigma, T9026), mouse anti-Ran (B.D. 610340), goat anti-GFP
(Abcam, 6673), mouse anti-RPL10A (Novus, 3G2), rabbit anti-RPL7 (Novus,
NB100-2269), and rabbit anti-RPS6 (Abcam, ab40820).
Co-immunoprecipitation
Min6 cells were lysed in buffer containing 20mM Tris pH 8.0, 137 mM NaCl, 1mM
MgCl2, 1mM CaCl2, 1% NP-40, 10% glycerol, protease inhibitor cocktail
(Millipore), and Benzonase (Sigma) at 12.5 U/mL. Lysates were rotated at 4°C
for 1 hour. Protein concentration was determined using a Micro BCA Protein
Assay Kit (Thermo). 1ug of primary antibody was added to lysate encompassing
500ug of protein and incubated overnight at 4°C. Protein A Dynabeads were
washed 3 times in lysis buffer then resuspended in lysate/antibody mixture and
incubated for 3 hours at 4°C. The immunoprecipitations were washed 4 times
with lysis buffer then eluted in NuPAGE LDS Sample Buffer (Invitrogen) by
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heating at 70°C for 10 minutes. Eluted proteins and input samples were analyzed
by western blot.
TRAP
TRAP was performed as described (Heiman et al., 2008), with minor
modifications. Briefly, after stress treatments of GFP-RPL10A Min6 cells,
cycloheximide (Sigma) was added to the culture media at 100ug/mL for 10
minutes prior to washing 2X with cold PBS. Cells were lysed and protein
concentration was measured by BCA (Thermo). Total RNA was isolated (1-5%
input) with the RNeasy Mini Kit (Qiagen). For IP RNA, cell lysates encompassing
200ug of protein were added to Protein G Dynabeads bound to GFP antibodies
(19C8 and 19F7, Memorial Sloan-Kettering Monoclonal Antibody Facility) and
incubated overnight at 4°C. The next day, the beads were washed 4X with high
salt buffer, as described8. IP RNA was eluted from beads in RLT buffer and
extracted using the RNeasy Mini Kit. Ribosome occupancy was determined by
dividing transcript abundance for each gene in the IP RNA fraction by its level in
the Total RNA fraction. For TRAP followed by RT-qPCR, RNA was reverse
transcribed with random hexamers and Superscript III (Invitrogen) and transcript
abundance was first normalized to HPRT for each fraction before determining
ribosome occupancy.
RNA immunoprecipitation
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RNA immunoprecipitation was performed using rabbit anti-hnRNPK (Bethyl
Laboratories, A300-674A) or rabbit anti-PCBP1/2 antibodies (Liebhaber lab).
Antibodies or IgG were bound to Protein A Dynabeads in buffer containing 20mM
HEPES pH 7.4, 5mM MgCl2, 150mM KCl, 2mM DTT, 1% NP-40. Min6 cells were
lysed in buffer containing 50mM Tris pH 8.0, 150mM NaCl, and 1% NP-40 with
RNase, protease, and phosphatase inhibitors. Total RNA was extracted from
lysate (10% input) using RNeasy Mini Kit (Qiagen). Lysate encompassing 75ug
of protein was added to beads bound to antibody for hnRNPK or PCBP1/2 and
an IgG control, then incubated overnight at 4°C. The next day, IPs were washed
with buffer containing 20mM HEPES pH 7.4, 5mM MgCl2, 350mM KCl, 2mM
DTT, 1% NP-40, and RNase inhibitors. RNA was eluted from beads in RLT buffer
(Qiagen) and RNA was isolated using RNeasy Mini Kit (Qiagen). For RIP
followed by RT-qPCR, enrichment was calculated by first normalizing transcript
abundance in IP RNA to that in total RNA and then to the IgG control.
CRISPR design and cloning
CRISPR gRNAs were designed using http://crispr.mit.edu/ to minimize off-target
binding (ROSA26: AAGATGGGCGGGAGTCTTCT, hnRNPK:	
  
GTTTAATACTTACGTCTGTA, PCBP1: TCGGCTGCTGATGCACGGAA,
PCBP2: GACACCGGTGTGATTGAAGG). gRNAs were cloned into
lentiCRISPRv2, as described (Sanjana et al., 2014).
RNA-seq and analysis
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RNA was isolated using the RNeasy Mini Kit (Qiagen). Libraries were prepared
using NEB Next Ultra RNA Library Prep Kit according to manufacturer’s
instructions with polyA enrichment followed by paired-end sequencing of 150bp
using HiSeq (Illumina). Reads were mapped to mm10 using TopHat2 (Kim et al.,
2013) and read counts per gene were determined using featureCounts (Liao et
al., 2014). For TRAP-seq analysis, ribosome occupancy was calculated by
dividing normalized gene counts in the IP RNA samples by that in the total RNA
samples. Differential expression analysis was performed using edgeR (Robinson
et al., 2010) with significant genes called using fold-change cutoffs of greater
than 1.5 or less than -1.5 and FDR less than 0.05. Gene ontology analysis was
performed using DAVID (Huang et al., 2009). For RIP-seq analysis, edgeR was
used to determine enrichment in the hnRNPK immunoprecipitated RNA
compared to total RNA with significant genes called using a fold-change cutoff of
greater than 1.5 and FDR less than 1x10-4. An IgG control was performed but not
sequenced because no RNA was detected in the pull-down by Qubit RNA High
Sensitivity quantitation. The overlap between RNA-seq data sets was determined
using hypergeometric tests.
Statistics
Data are presented as mean ± standard error of the mean unless otherwise
noted in figure legends. Statistical analyses were performed using GraphPad
PRISM 7 software. Statistical tests used are noted in figure legends and include
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unpaired two-tailed Student’s t-test, one-way analysis of variance (ANOVA), twoway ANOVA, and hypergeometric test.
Motif analysis
De novo motif discovery was performed using the MEME software suite (Bailey
et al., 2009) with the following parameters: strand-specific search, motif width 410. For motif frequency comparison, control sets of genes were generated by
randomly selecting 100 genes 10 times from a list of genes with detectable
expression in Min6 cells but not meeting the criteria for differential ribosome
occupancy with PDX1 deficiency. The FIMO tool of the MEME suite (Bailey et al.,
2009) was used to determine motif frequencies. The Tomtom tool of the MEME
suite (Bailey et al., 2009) was used to compare discovered motifs to a database
of motifs recognized by RBPs (Ray et al., 2014).
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Gene Name

Forward primer

Reverse primer

HPRT

TGCTCGAGATGTCATGAAGGA

CCAGCAGGTCAGCAAAGAACT

Beta_actin

gctacagcttcaccaccaca

tctccagggaggaagaggat

ATF4

GCAGTGTTGCTGTAACGGACA

CGCTGTTCAGGAAGCTCATCT

JunD

TCAAGACCCTCAAAAGCCAGA

CGTGGCTGAGGACTTTCTGTT

hnRNPK

GAAGAAACCTTCCCCAACACC

CGCAATTCAACCATCTCATCA

NOS2

CTGAACTTGAGCGAGGAGCAG

TTGCCCCATAGGAAAAGACTG

Ccl2

CAGGTGTCCCAAAGAAGCTGT

ATTTGGTTCCGATCCAGGTTT

Ptgs2

CCTCCTGGAACATGGACTCAC

GCTTGTACAGCAATTGGCACA

Steap4

TGCCATCAGTAAGCAACATGG

TACACCAAAGTGTGGGCTGTG

Cxcl1

TCCAGAGCTTGAAGGTGTTGC

TTCTGAACCAAGGGAGCTTCA

Cxcl2

TGCCAAGGGTTGACTTCAAGA

AACTTTTTGACCGCCCTTGAG

Lrrtm2

ACTGAATGCAGCCTCCAATGT

AGGGCAGGCAGCATTTTTAAT

Lamc2

GGGCAATGCCACTTTTTATGA

TCTCTTCATGGCCTCTTCAGC

Crispld2

TTGGGCTCCTGTGTATGGAAC

ACATCTGCATAGCCACCAACC

Inhba

GATCATCACCTTTGCCGAGTC

TTCTGCACGCTCCACTACTGA

GAPDH

aggccggtgctgagtatgtc

tgcctgcttcaccaccttct

SOD2

GCCTACGTGAACAATCTCAACG

TTGAACTTCAGTGCAGGCTGA

SOD3

GAGTCCAGCTTCGACCTAGCA

CTCCATCCAGATCTCCAGCAC

ALDH2

GATTGGCGGATCTCATTGAAC

TTCAGGACCATGTCCAAATCC

GPX1

GACTGGTGGTGCTCGGTTTC

ACCAGGTCGGACGTACTTGAG

MGST1

CGCATTCCAGAGGATAACCAA

GTTCCACCTTCTCGTCAGTGC

RDH10

TGTAGACACGGGCATGTTCAG

CAGTGAGGATGGCCCTCATAG

CDO1

TGGGCTTTGTATGCCAAATTC

ACCCCAGCACAGAATCATCAG

SCD1

GCTCAGTCCCTGTTTGTTTGC

CTTTGGAGGGTGGACAGACAC

G6PDX

AACCCCAATGGAGAAGGAGAA

GAGGACAGCTGCTGCAAAAGT

DHX9

CCACACAAGTTCCACAGTACATT

TTTCCAGGCTCTTCTCCTCTC

DDX1

AGTGGCAGATGAACCCATATGA

CCTCATAGTAGTGCTTCCCTTTC

DDX3X

GAAAATGGAAGATATGGCCGTCG

TTCAGCACCACCATAAACCACG

18S

AACCCGTTGAACCCCATT

CCATCCAATCGGTAGTAGCG

Neat1

tcttggggccacattaatcac

gaggggcaagagtagggaaga

PDX1_PT

TGAAATCCACCAAAGCTCACG

tgaaggcagtagcagccaagt

Table 1. Primer sequences for RT-qPCR
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2.4 Results
2.4.1 Establishment of TRAP in Min6 cells
In order to detect changes in mRNA translation on a genome-wide scale, we
have employed the Translating Ribosome Affinity Purificaition (TRAP)
methodology in which expression of a tagged ribosomal subunit (GFP-RPL10A)
is used to immunoprecipitate ribosomes and their associated mRNA (Doyle et al.,
2008). This approach can be used to detect changes in ribosome occupancy, or
the density of ribosomes binding to mRNA, which serves as a proxy for the
efficiency of translation (Zhou et al., 2013b). To use TRAP in Min6 cells, we
established a stable cell line using retroviral transduction to deliver the GFPRPL10A transgene. This allowed for the isolation of intact ribosomes and their
associated mRNAs by GFP immunoprecipitation (Figure 2.1a-c). To confirm that
this approach can detect dynamic shifts in ribosome occupancy, TRAP was
performed in GFP-RPL10A Min6 cells treated with thapsigargin to induce ER
stress, and ribosome occupancy was determined by normalizing transcript
abundance in the ribosome pull-down fraction to that in total RNA. This gave a
near doubling of ribosome occupancy for the stress-responsive factor ATF4
during thapsigargin treatment (Figure 2.1d), consistent with previous findings
using polysome profiling (Guan et al., 2014; Hatanaka et al., 2014).
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Figure 2.1. TRAP in GFP-L10a Min6 cells pulls down ribosome-associated mRNA and
detects shifts in the ribosome occupancy of ATF4 during ER stress.
a, Immunoprecipitation of GFP in Min6 cells with stable overexpression of either GFP only or the
GFP-RPL10A fusion protein, as per TRAP protocol. Compared to GFP only, immunoprecipitation
of GFP-RPL10A enriches for the ribosomal proteins RPL7 and RPS6. b, Comparison of input
(Inp) and unbound (UB, supernatant of IP reaction) fractions shows that immunoprecipitation of
GFP led to depletion of ribosomal proteins RPL10A, RPL7, and RPS6 from the UB fractions for
GFP-RPL10A Min6 cells, but not for cells only expressing GFP. c, Representative bioanalyzer
traces on IP RNA showing that TRAP in Min6 cells allows for the isolation of high quality,
ribosome-associated RNA with overexpression of GFP-RPL10A transgene, but not GFP only. d,
TRAP in GFP-RPL10a Min6 cells was used to determine ribosome occupancy after 3hr treatment
with thapsigargin (Tg, 1uM) or vehicle (DMSO), followed by RT-qPCR of IP RNA and Total RNA
(n=3). P values were calculated by unpaired two-tailed Student’s t-test. * = p < 0.05.
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2.4.2 TRAP-seq during PDX1 deficiency
To screen for translationally regulated genes in β cells, we used deficiency of the
transcription factor PDX1 as a means to disrupt normal β cell homeostasis. PDX1
is a human diabetes gene (Stoffers et al., 1997b), and reduced PDX1 levels
cause β cell dysfunction and an impaired stress response (Brissova et al., 2002;
Sachdeva et al., 2009). Given these connections to human disease and β cell
stress, we reasoned that PDX1 deficiency was a promising model to uncover
functionally important translational controls in β cells. Indeed, TRAP-seq on GFPRPL10A Min6 cells with siRNA-mediated depletion of PDX1 identified 53 genes
with an increase in ribosome occupancy after PDX1 depletion while 57 genes
had a reduction (Figure 2.2a,b). A subset of these genes demonstrated no
change in total mRNA abundance but a significant change in ribosome
association (Figure 2.2c), indicating that the dominant regulatory mechanism for
these genes is post-transcriptional. This list included several genes with known
importance in β cells such as the transcription factor Nkx2-2, a critical regulator
of β cell identity and function (Doyle and Sussel, 2007; Gutiérrez et al., 2017).
We also identified several genes that have been implicated in various stress
responses in other cell types. Of particular interest was the transcription factor
JUND, which is important for redox homeostasis in other cell types (Gerald et al.,
2004; Paneni et al., 2013) but whose role in β cells is unknown.
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Figure 2.2. TRAP in GFP-L10a Min6 detects shifts in ribosome occupancy after PDX1
depletion.
a,b, Volcano plot depicting changes in ribosome occupancy with Pdx1 depletion (a) and
comparison of the change in transcript abundance with Pdx1 depletion in the IP RNA fraction to
that in the Total RNA fraction (b) as determined by TRAP-seq in GFP-RPL10a Min6 cells
transfected with siRNA targeting Pdx1 or non-targeting (NT) control (n=3). Significant changes in
ribosome occupancy shown in red (upregulated) or blue (downregulated). c, Heatmap showing
genes identified by TRAP-seq as having significant changes in ribosome occupancy but no
significant change in total RNA levels after Pdx1 depletion.
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2.4.3 Post-transcriptional regulation by the poly(C)-binding proteins
To investigate the mechanism underlying the translational regulation of these
genes, a de novo motif analysis was used to search for a common regulatory
element within the untranslated regions (UTRs) of genes from our TRAP screen
(Figure 2.2a). This approach identified 4 motifs as occurring more frequently in
the UTRs of genes with increased ribosome occupancy than expected by chance
(Figure 2.3a). However, when compared to the motif frequency (number of motifs
per sequence length) in UTRs of randomly sampled control genes, two of these
motifs showed no significant enrichment over controls, indicating they are
generally enriched in UTRs (Figure 2.3b). In contrast, the motif frequency for the
cytosine-rich motif 3 was significantly higher in the upregulated genes compared
to that in both the downregulated genes and control genes, and it was specifically
enriched in the 3’UTR of the upregulated genes (Figure 2.3b). 31 of the 53 genes
with increased ribosome occupancy after PDX1 depletion contained at least one
occurrence of motif 3 in their 3’ UTR. Further, the 3’UTRs of Jund and Nkx2-2
contain sequence elements matching this cytosine-rich motif.
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Figure 2.3. Enrichment of a cytosine-rich motif in genes from TRAP-seq identified by de
novo motif analysis.
a, Motifs found by de novo motif analysis on UTRs of genes with increased ribosome occupancy
after PDX1 depletion. b, Assessment of motif frequencies in UTRs of genes with changes in
ribosome occupancy after PDX1 depletion and sets of randomly sampled control genes. Box, 25–
75th percentile; bar, median; whiskers, range. c, Comparison of Motif 3 to binding motifs for
hnRNPK, PCBP1, and PCBP2, as depicted.
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We hypothesized that the cytosine-rich motif 3 serves as the binding site for an
RBP that post-transcriptionally regulates these target mRNAs. Comparison of
motif 3 to a database of motifs for RBPs (Ray et al., 2014) found a high similarity
to the motif recognized by the poly(C)-binding protein family of RBPs, including
the members PCBP1, PCBP2, and hnRNPK (Figure 2.3c), which are known
regulators of mRNA translation (Bomsztyk et al., 2004; Makeyev and Liebhaber,
2002). Indeed, RNA immunoprecipitation (RIP) for PCBP1, PCBP2, or hnRNPK
demonstrated that the mRNAs encoding JUND and NKX2-2 are significantly
bound by these RBPs in Min6 cells compared to housekeeping genes (Figure
2.4a-c). The interaction between hnRNPK and the JUND mRNA was also
confirmed in eCLIP data for HepG2 and K562 cells and was specifically localized
in the 3’UTR of this transcript (The ENCODE Project Consortium et al., 2012)
(Figure 2.4d).
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Figure 2.4. PCPB1, PCBP2, and hnRNPK bind to the mRNAs encoding NXK2-2 and JUND.
a-c, Interaction of PCBP1 (a), PCBP2 (b), or hnRNPK (c) with the mRNAs encoding NKX2-2 and
JUND compared to housekeeping controls, as determined by RNA immunoprecipitation (n=3-4).
P values were calculated by a two-way ANOVA. * = p < 0.05. d, eCLIP binding peaks for
hnRNPK show binding in the 3’UTR of JUND in both HepG2 and K562 cells.
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To broadly examine the connection between hnRNPK and genes from our
TRAP-seq experiment, RIP for hnRNPK followed by RNA-seq (RIP-seq) was
performed in Min6 cells treated with glucolipotoxicity (Figure 2.5a). As a control,
RNA-seq on input RNA was also performed. To determine enrichment for
hnRNPK binding, the immunoprecipitated RNA was compared to total RNA. An
IgG control was also performed but not sequenced because no RNA was
detected in this group. Comparison of RIP-seq and TRAP-seq results showed
that 64% of genes with increased ribosome occupancy and at least one
occurrence of motif 3, including JUND and NKX2-2, were enriched for hnRNPK
binding, constituting a statistically significant overlap (Figure 2.5b, p = 1.0x10-4).
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Figure 2.5. Detection of mRNAs bound by hnRNPK via RIP-seq.
a, Comparison of transcript expression level to its enrichment in the hnRNPK IP over total RNA
as determined by RIP-seq for hnRNPK in Min6 cells treated with glucolipotoxicity. Genes with a
statistically significant enrichment in hnRNPK binding are shown in red (n=3). b, Comparison of
the percentage of genes enriched for hnRNPK binding by RIP-seq. Control group is 100 sets of
100 randomly sampled genes from all expressed genes. Box, 25–75th percentile; bar, median;
whiskers, range. Increased ribosome occupancy (RO) and decreased RO groups are genes
determined to have significant changes in RO by TRAP-seq. Motif 3 group is the set of genes that
had increased RO and contained at least one occurrence of motif 3 in the 3’ UTR.
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Given the interaction between the PCBPs and the mRNAs encoding JUND and
NKX2-2, we next investigated whether loss of these RBPs would impact JUND or
NKX2-2 expression. PCBP1 and PCBP2 have high amino acid sequence
homology and serve redundant roles for some biological processes. For
example, co-depletion of PCBP1/2, but not depletion of either individually, leads
to increased mRNA stability of CDKN1A in K562 cells (Waggoner et al., 2009).
Therefore, we targeted both PCBP1/2 in Min6 with CRISPR-Cas9, which allowed
for efficient co-depletion of these factors. Interestingly, loss of PCBP1/2 led to a
significant reduction in protein levels of NKX2-2 and JUND (Figure 2.6a). In
contrast, the transcript level of JUND was slightly increased after loss of
PCBP1/2, indicating that the reduction in protein is not caused by reduced
transcription, but rather is post-transcriptional (Figure 2.6b). For NKX2-2, there
was a slight reduction in mRNA levels but a significant increase in primary
transcript, which was measured using primers spanning an intron-exon junction
(Figure 2.6b). This is consistent with loss of PCBP1/2 leading to reduced stability
of the NKX2-2 mRNA and/or reduced mRNA translation. Together, these findings
implicate PCBP1/2 as post-transcriptional regulators of NKX2-2 and JUND, likely
through a combination of reduced translation and mRNA stability. In contrast,
CRISPR-mediated depletion of hnRNPK did not impact protein levels of NKX2-2
or JUND under baseline conditions (Figure 2.6c).
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Figure 2.6. Loss of PCBP1/2, but not hnRNPK, reduces NKX2-2 and JUND protein levels
under baseline conditions.
a, CRISPR-mediated depletion of PCBP1 and PCBP2 in Min6 cells causes reduction in NKX2-2
and JUND protein levels 8 days post-transduction, as assessed by Western blot (n=3). b, RTqPCR analysis of NKX2-2, NKX2-2 primary transcript (PT), and JUND in Min6 cells with CRISPRmediated depletion of PCBP1/2, 8 days post-transduction (n=3). c, Western blot depicting no
change in NKX2-2 or JUND protein levels after CRISPR-mediated knockout of hnRNPK in Min6
cells, 8 days post-transduction (n=3). P values were calculated by unpaired two-tailed Student’s ttest. * = p < 0.05.
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2.4.4 Impact of the PCBPs on insulin secretion in Min6 cells
NKX2-2 is a critical regulator of β cell identity, and genetic deletion of NKX2-2 in
β cells leads to impaired insulin secretion in mice (Gutiérrez et al., 2017). Given
their role in the post-transcriptional regulation of NKX2-2, we hypothesized that
loss of PCBP1/2 would also negatively impact insulin secretion. To test this, we
performed glucose-stimulated insulin secretion assays in Min6 cells after
CRISPR-mediated depletion of PCBP1/2. As expected, Min6 cells in the
ROSA26 control group secreted approximately 10 times as much insulin when
exposed to high glucose levels (25mM) compared to low glucose (2.5mM)
(Figure 2.7a,b). Interestingly, loss of PCBP1/2 led to a significant reduction in
insulin secretion at 25mM compared to the ROSA26 group, and it caused a
reduction in the fold-change from low to high glucose (Figure 2.7a,b). In contrast,
there was no change in the total insulin content of the cells after loss of PCBP1/2
(Figure 2.7c), which indicates that there is not a defect in the synthesis of insulin
but rather in its secretion.
To assess whether loss of hnRNPK also impacts insulin secretion, we measured
glucose-stimulated insulin secretion in Min6 cells after CRISPR-mediated
depletion of hnRNPK. Similar to the PCBP1/2 depletion, loss of hnRNPK led to a
significant impairment in insulin secretion at high glucose levels compared to the
ROSA26 group and a reduction in the fold-change from low to high glucose
concentrations (Figure 2.7d,e). In contrast to PCBP1/2, however, loss of
hnRNPK led to a significant increase in insulin content, which was independent
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of changes in insulin mRNA (Figure 2.7f,g). Together these data indicate that
hnRNPK is required for normal insulin secretion in Min6 cells. This defect cannot
be explained by reduced insulin levels as there was actually an increase in the
total insulin content of Min6 cells with depletion of hnRNPK. Instead, these
findings suggest a secretory defect in these cells. The cause of elevated insulin
levels is unclear but appears to be independent of insulin mRNA transcription.
Although loss of hnRNPK did not affect NKX2-2 or JUND levels under baseline
conditions (Figure 2.6), it did bind to a significant number of genes from our
TRAP screen containing the polyC motif by RIP-seq. Interestingly, our RIP-seq
data indicated that hnRNPK binds not only to NKX2-2, but also other
transcription factors critical for maintenance of β cell identity, including PDX1,
NKX6-1, and FOXO1. To assess whether loss of hnRNPK may impact β cell
identity, we depleted hnRNPK in Min6 cells using CRISPR-Cas9 and assessed
levels of NGN3, a marker of pancreatic endocrine progenitor cells that has been
used to identify β cell “dedifferentiation” (Talchai et al., 2012). Interestingly, loss
of hnRNPK led to a significant increase in NGN3 levels in Min6 cells (Figure
2.7h), suggesting this factor may be important for maintenance of β cell identity.
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Figure 2.7. Loss of PCBP1/2 or hnRNPK impairs insulin secretion from Min6 cells.
a-f, Assessment of glucose-stimulated insulin secretion (GSIS) in Min6 cells with CRISPRmediated depletion of PCBP1/2 (a-c) or hnRNPK (d-f). Data presented as the amount of insulin
secreted into media during a 30-minute incubation in low glucose (LG, 2.5mM) or high glucose
(HG, 25mM) conditions with normalization to the total insulin content of the cells (a,d). GSIS
results shown as the fold change in insulin secretion from LG to HG conditions (b,e). Total insulin
content determined for each group with normalization to total protein levels (c,f). For GSIS, each
group run in quadruplicate. g,h, RT-qPCR analysis of INS1 (n=4) (g) and NGN3 (n=3) (h) in Min6
cells with CRISPR-mediated depletion of hnRNPK, 8 days post-transduction. P values were
calculated by unpaired two-tailed Student’s t-test, except in (a,d) in which a 2-way ANOVA was
used. * = p < 0.05.
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2.5 Discussion
To study translational regulation in pancreatic β cells, we have adapted the
TRAP methodology for use in a Min6 stable cell line expressing the GFPRPL10A transgene. One advantage of TRAP over other methodologies, such as
ribosome profiling, is that expression of the transgene can be controlled in a cell
type-specific manner. This is particularly attractive for assessing changes in
ribosome occupancy in vivo as β cells reside alongside other endocrine cell types
in pancreatic islets. Thus, an exciting and promising direction is to assess
translational regulation in β cells under in vivo stress conditions, such as a high
fat diet, using TRAP. This will present some challenges given the limiting material
of primary islets, however, the continuing improvements in sequencing
technologies for low input RNA indicate that this approach is likely to be
successful.
Another enticing application of this methodology is studying translational
regulation in human islets by lentiviral delivery of the GFP-L10a transgene
expressed from a β cell-specific promoter. Since β cells represent a smaller
fraction of the islet cell population in human compared to mouse islets, the cell
type specificity of TRAP is particularly important in this context. One large hurdle
to overcome, however, will be the time required for ribosomal turnover to occur.
For example, the half-lives of ribosomal proteins were determined to be
approximately 9 days in rat brain tissue (Retz and Steele, 1980). This suggests
that it may require prolonged culturing of human islets for a sufficient number of
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ribosomes to incorporate the GFP-RPL10a protein. The time required for
adequate incorporation will need to be determined empirically, but limitations on
culturing human islets for extended periods may cause this approach to be
problematic.
As a preliminary TRAP screen, we have used PDX1 deficiency to uncover novel
translational regulation in β cells. This method, however, could be applied to a
variety of stresses or stimuli that are relevant for β cell biology. For example, ER
stress and oxidative stress are thought to contribute to β cell demise in T2D.
Therefore, a thorough characterization of translational changes that occur in
response to these stresses may uncover novel mechanisms for adaptation to
stress. Similarly, high glucose levels have been reported to acutely increase
translation of insulin mRNA (Itoh and Okamoto, 1980), but the extent to which
this occurs for other mRNAs under these conditions is unknown. TRAP could
also be applied to determine the subset of mRNAs translationally regulated by
particular RNA binding proteins in loss-of-function studies. Taken together with
genome-wide assessments of RBP binding, such as eCLIP (Van Nostrand et al.,
2016), this could provide a comprehensive picture of the translational targets for
a particular RBP.
TRAP can detect shifts in the ribosome occupancy of mRNAs on a genome-wide
scale, however, it cannot detect changes in the usage of translation initiation
sites due to the sequencing of full-length mRNA. This is particularly notable
because translation of an alternative open reading frame of insulin generates an
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immunogenic peptide that is potentially contributing to type 1 diabetes
pathogenesis (Kracht et al., 2017). Therefore mapping the usage of alternative
translation initiation sites on a genome-wide scale, and assessing conditions that
alter the relative usage of these sites, may advance our understanding of β cell
autoimmunity. To address this question, TRAP could be adapted to include an
RNase digestion step prior to immunoprecipitation, which would generate
ribosome-protected RNA fragments similar to ribosome profiling. This would
allow for the assessment of ribosome localization along mRNAs while retaining
the advantage of cell type-specificity.
A de novo motif analysis on genes from our TRAP screen identified enrichment
of a poly(C) motif in the 3’ UTR of genes with increased ribosome occupancy,
which is similar to the preferred binding sequence for the poly(C)-binding protein
family of RNA binding proteins. Two of the genes with enrichment of this motif
(NKX2-2 and JUND) are also bound by the PCBPs by RIP and require PCBP1/2
for normal expression under baseline conditions. These data suggest that these
RBPs directly regulate the expression of NKX2-2 and JUND. However, we
cannot rule out the possibility that loss of PCBP1/2 indirectly affects the
expression of these genes. One approach to expand on the level of regulation is
to use a reporter gene flanked by the 5’ and 3’UTR of the gene of interest.
Deletion constructs can then be generated to assess the importance of the
poly(C) regions for maintaining normal expression levels or for the control of
stress-dependent changes in expression. Although this approach is commonly
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used for this purpose, we have been unsuccessful in our attempts to model the
regulation of NKX2-2 or JUND using reporter assays. There are many reasons
that an artificial reporter gene may not fully recapitulate the complex regulation of
endogenous genes. For example, RNA secondary structure may be altered due
to presence of remaining plasmid sequence, or the assembly of RNP complexes
may require factors recruited by the local chromatin environment. Nevertheless,
we cannot currently rule out the possibility that the PCBPs regulate NKX2-2 or
JUND independent of binding to 3’UTR poly(C) motifs. In the future, it would be
interesting to generate deletions of the poly(C) motifs by genome editing to
assess their impact on gene expression and stress adaptation.
Loss of PCBP1/2 or hnRNPK leads to impaired glucose-stimulated insulin
secretion in Min6 cells. As an insulinoma cell line, Min6 cells are an imperfect
model of primary β cells. However, our methodology provides a robust increase
in insulin secretion from Min6 cells during high glucose conditions compared to
low glucose, suggesting these cells are a useful model for preliminary
experiments. To follow-up on these results, our lab is actively characterizing the
impacts of β cell-specific ablation of PCBP1 and PCBP2 in vivo on glucose
homeostasis and insulin secretion.
The exact mechanisms by which loss of PCBP1/2 or hnRNPK reduces insulin
secretion are currently unclear. In both cases, total cellular insulin levels cannot
explain this phenotype, but rather there is likely a secretory impairment in these
cells. One useful approach to further localize this defect along the pathway of
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glucose-stimulated insulin secretion is calcium imaging. For example, if loss of
these RBPs was associated with normal glucose-stimulated calcium influx, it
would suggest there is not a problem with glucose sensing but rather in a more
distal step such as insulin granule exocytosis. An in-depth investigation of the
mRNA targets regulated by the PCBPs in β cells will also shed light on the
precise cause of the impaired insulin secretion. This objective is complicated by
the fact that the PCBPs can regulate gene expression at many levels including
transcription, splicing, mRNA stability, and translation. Nevertheless, a
systematic examination of gene expression changes downstream of PCBP
depletion holds promise to elucidate novel regulatory networks governing β cell
functionality.
Loss of β cell identity has received growing attention as a cause of impaired
insulin secretion in T2D. Therefore, it will be important to identify the full inventory
of factors shaping β cell identity and to understand the dynamics and adaptability
of these gene regulatory networks during environmental perturbations. Our
finding that loss of hnRNPK in Min6 cells leads to an upregulation of NGN3, a
marker of endocrine progenitor cells, suggests that hnRNPK may be a novel
regulator of β cell identity. On the other hand, hnRNPK depletion leads to
increased insulin levels in Min6 cells, which seems to contradict the adoption of
an endocrine progenitor fate. One explanation for these findings is that loss of
hnRNPK leads to the formation of distinct subpopulations of cells, including a
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subset of NGN3+ cells. An interesting approach to assess this possibility is
performing single cell RNA-seq on β cells after depletion of hnRNPK.
The role of hnRNPK in regulating β cell identity is particularly interesting because
it can integrate various signaling pathways with multiple levels of gene
expression, allowing for the swift reshaping of regulatory networks. hnRNPK
binds to the mRNAs of several genes with critical roles in β cell identity, including
NKX2-2, PDX1, NKX6-1, and FOXO1. However, we have been unable to identify
changes in the expression level of NKX2-2 or PDX1 with loss of hnRNPK. One
possible explanation for these findings is that hnRNPK regulates these genes
under stress conditions or as cells recover from stress, but not under baseline
conditions. PCBP1/2 may also be important for maintenance of β cell identity as
loss of these factors leads to reduced NKX2-2 levels. An active area of
investigation for our lab is to better understand whether PCBP1/2 depletion
causes loss of β cell identity and reprogramming to a new cell type. 	
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CHAPTER 3: JUND PROMOTES β CELL APOPTOSIS AND OXIDATIVE
STRESS DURING METABOLIC STRESS
3.1 Summary
During the development of T2D, prolonged oxidative stress conditions contribute
to β cell dysfunction and apoptosis; however, the factors shaping the oxidative
stress response in β cells is poorly understood. By focusing on translational
regulation, we have identified the transcription factor JUND as a potential stressresponsive factor in β cells. Indeed, exposure of mouse islets or Min6 cells to
metabolic stress caused by high glucose and free fatty acid levels leads to the
translational induction of JUND. This post-transcriptional regulation of JUND also
occurs during in vivo stress conditions and is conserved in human islets.
Surprisingly, depletion of JUND in β cells reduces oxidative stress and apoptosis
caused by metabolic stress. Consistent with this, JUND regulates the
transcription of pro-oxidant and pro-inflammatory genes in β cells. Furthermore,
there is a significant overlap between JUND target genes and genes increased in
islets from diabetic db/db mice. Thus, we have uncovered the novel translational
regulation of JUND during metabolic stress and implicate this transcription factor
in activating a maladaptive response in β cells during pathophysiologically
relevant conditions.
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3.2 Introduction
In T2D, β cell dysfunction occurs due to prolonged stress conditions that impact
the function and viability of these cells. Of particular importance is chronic
oxidative stress, or the accumulation of reactive oxygen/nitrogen species
(ROS/RNS) in the cell. Chronic oxidative stress has been suggested to impact
various aspects of β cell function including reduced expression of key β cell
genes such as those encoding insulin, PDX1, and MAFA (Jonas et al., 1999;
Robertson et al., 2007). In fact, β cells are though to be particularly vulnerable to
oxidative stress due to low expression of antioxidant genes (Lenzen et al., 1996).
Furthermore in animal models of diabetes, antioxidant treatment can reverse the
onset of hyperglycemia by improving β cell function (Han et al., 2015), however,
the use of antioxidants for treatment of humans with T2D has as of yet not
proven beneficial (Rochette et al., 2014).
The cause of oxidative stress in β cells during T2D is complex and may be
manifold. Part of this complexity arises due to the generation of ROS in various
cellular compartments. For example, ROS are a normal byproduct of oxidative
phosphorylation in mitochondria, and increased flux through the electron
transport chain can cause increased mitochondrial oxidative stress (Sakai et al.,
2003). On the other hand, high levels of free fatty acids cause lipid oxidation to
occur predominantly in peroxisomes, leading to hydrogen peroxide generation in
this organelle (Gehrmann et al., 2010). Additionally, many cytoplasmic enzymes,
such as NADPH oxidases, generate ROS and may be induced in β cells under
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stress conditions, such as cytokine treatment (Weaver et al., 2014). It is unclear
to what extent these different sources of ROS contribute to β cell dysfunction in
T2D. This is further complicated by the fact that different models of β cell stress
(ie: glucotoxicity vs. lipotoxicity) implicate different ROS sources as the critical
mediators of dysfunction (Elsner et al., 2010; Sakai et al., 2003).
Despite extensive evidence linking oxidative stress to β cell demise in T2D, the
factors shaping the oxidative stress response in β cells, and how these factors
are regulated during disease progression, are unclear. For this reason, we were
particularly interested in further exploring our finding that the transcription factor
JUND may be translationally regulated in β cells (Figure 2.2), because this factor
has been linked to redox homeostasis in other cell types (Gerald et al., 2004;
Paneni et al., 2013).
JUND is a member of the Jun family of transcription factors, which also includes
C-JUN and JUNB. These factors form either homo- or hetero-dimers among
themselves or with factors from other transcription factor families, including Fos,
Atf, and Maf. Importantly, the composition of these dimers will dictate the DNA
binding preference and transcriptional effect of JUND (Mechta-Grigoriou et al.,
2001). Consequently, the transcriptional and phenotypic effects of JUND may
vary across cell types based on the relative abundance of its binding partners.
The effect of JUND on oxidative stress has mostly been studied in the context of
a global JUND knockout mouse model. Fibroblasts and endothelial cells isolated
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from these mice display elevated ROS levels compared to those from wild type
mice, which was linked to reduced expression of antioxidant genes (Gerald et al.,
2004; Paneni et al., 2013). JUND knockout mice have a shortened lifespan and
hyperinsulinemic hypoglycemia, and pancreatic islets from these mice are
hypervascularized (Laurent et al., 2008). However, whether loss of JUND also
causes cell-autonomous changes in β cells has not been explored.
Although the role of JUND in β cells has not been studied, it is worth noting that
one factor known to interact with JUND and regulate its function is MENIN, a
transcriptional cofactor with repressive function. Mutations in the gene encoding
this cofactor, Men1, cause multiple endocrine neoplasia, type 1 (MEN1). This
disorder is characterized by tumors of the pancreatic islets, parathyriods, anterior
pituitary, and duodenum (Feng et al., 2017). MENIN represses the transcriptional
activity of JUND (Agarwal et al., 1999), raising the intriguing possibility that JUND
may be important for regulating β cell proliferation. However, whether this
interaction between JUND and MENIN is important for the role of either factor in
β cells is unknown.
One approach to address the role of JUND in β cells would be to use a mouse
model in which the gene encoding JUND is flanked by loxP sites to allow for its
conditional ablation using a β cell-specific Cre driver. Unfortunately, a JUND
conditional knockout mouse is currently unavailable. To circumvent this problem,
we have used lentiviral delivery of an shRNA targeting JUND from the rat insulin
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promoter to achieve β cell-specific depletion of JUND in primary mouse islets,
leading to our novel findings that depletion of JUND in β cells reduces apoptosis
and oxidative stress during glucolipotoxicity.
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3.3 Materials and Methods
Animals
Animal studies were approved by the University of Pennsylvania Institutional
Animal Care and Use Committee. Wild type CD1 males were purchased from
Jackson Laboratory. Male db/db mice (C57BLKS/J Leprdb/db) or db/+ mice
(C57BLKS/J Leprdb/+) were purchased from Jackson Laboratory. Blood glucose
levels were determined by handheld glucometers (One Touch). Serum NEFA
levels were determined by fluorometric assay (Abcam). Mice were housed in a
12hr light/dark cycle and had ad libitum access to food.
Lentivirus production
293T cells were transfected for 8 hrs in OptiMEM using Lipofectamine 2000
(Invitrogen), after which the media was changed to standard high glucose
DMEM. psPAX2 and pMD2.G were used for packaging and envelope vectors.
These plasmids were a gift from Didier Trono (Addgene plasmid #12260 and #
12259). Media containing virus was collected 2 and 3 days post-transfection.
Ultracentrifugation of collected media (19,000rpm for 1.5hrs at 4°C) was used to
concentrate virus. Lentivirus was titered by RT-PCR (Sastry et al., 2002).
Islet isolation and culture
Mouse islets were isolated from 6-12 week old CD1 male mice unless otherwise
noted. Briefly, ductal inflation of the pancreas was performed followed by
collagenase digestion (Roche 11213873001). Islets were enriched by density
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gradient centrifugation with Ficoll-Paque (GE 45-001-751). After handpicking 3-4
times, islets were collected for RNA/protein isolation or cultured overnight for
recovery from isolation and stress treatments were started the next day.
Human islets were obtained through the NIH-supported Human Pancreas
Analysis Program via the University of Pennsylvania Islet Core facility. The islets
were harvested from non-diabetic deceased donors without any identifying
information at NIH-approved centers with informed consent and IRB approval at
the islet isolation centers. Human islet donor characteristics are provided below
in Table 2.
The culture media used for mouse and human islets was RPMI 1640 (11mM
glucose) supplemented with 10% FBS, 2mM glutamine, 1mM sodium pyruvate,
10mM HEPES, 1% antibiotic antimycotic (Thermo 15240096), and pH was
adjusted to 7.3-7.4.
Islet transductions
Lentiviral infection of mouse islets was performed as described (Jimenez-Moreno
et al., 2015). 100-200 islets were cultured overnight in serum-free islet media
containing lentivirus at an MOI of 20.
Palmitate preparation and glucolipotoxicity conditions
Palmitate (Sigma P9767) was dissolved in 50% ethanol at 65°C and diluted in
10% BSA to a concentration of 7mM. The mixture was incubated at 37°C for 1
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hour to allow for conjugation before diluting in culturing media to a final
concentration of 0.5mM. Control media was made by performing the same
procedure with 50% ethanol and no palmitate.
For islets, control media (described above) contained 11mM glucose with no
added palmitate. Media for glucolipotoxic conditions contained 25mM glucose
with 500uM palmitate.
For Min6, control media (DMEM) contained 5.6mM glucose with no added
palmitate while glucolipotoxic conditions had 25mM glucose and 500uM
palmitate.
RNA isolation and RT-qPCR
For islets, handpicked islets were washed 2X with cold PBS and RNA was
extracted using RNeasy Mini Kit (Qiagen). RNA was reverse transcribed using
oligo(dT) and Superscript III (Invitrogen). Quantitative PCR (BioRad CFX384)
was used to measure transcript abundance and normalized to HPRT. See Table
1 for a list of primer sequences used for these analyses.
Western blot
Proteins were separated by SDS-PAGE and immunoblotted with the following
antibodies: rabbit anti-JUND (Santa Cruz, sc-74), mouse anti-ATF4 (Santa Cruz,
sc-390063), rabbit anti-cleaved caspase-3 (Cell Signaling, 9664S), mouse antiTubulin (Sigma, T9026), and mouse anti-Ran (B.D. 610340).
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Cycloheximide chase assay
Min6 cells were cultured in control or glucolipotoxic conditions for 30hrs prior to
treatment with cycloheximide at a concentration of 200ug/mL. Cells here
harvested at 0hr, 3hr, 6hr, and 9hr time points post-cycloheximide treatment and
analyzed by western blot.
shRNA design and cloning
The lentiviral backbone was generated by cloning the rat insulin II promoter (-405
to +7 relative to the TSS), GFP, and the UltramiR mir-30 scaffold (Knott et al.,
2014) into pLenti CMV puro (Campeau et al., 2009) by PCR and Gibson
Assembly (replaced CMV promoter with rat insulin promoter). shRNA sequences
were designed using the shERWOOD algorithm (Knott et al., 2014) (shJunD:
AGCAGCTCAAACAGAAAGTCC, shNT: GCGCGATAGCGCTAATAATTT).
CRISPR design and cloning
CRISPR gRNAs were designed using http://crispr.mit.edu/ to minimize off-target
binding (ROSA26: AAGATGGGCGGGAGTCTTCT, JUND:
CAGCTTGCGCTTGCGGCATT). gRNAs were cloned into lentiCRISPR v2, as
described (Sanjana et al., 2014).
Immunofluorescence staining of isolated islets
Transduced islets were collected, dispersed to single cell suspension, washed in
PBS, and fixed for 10 minutes at room temperature in 4% PFA. Fixed cells were
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attached to slides using cytospin. Following permeabilization (0.1% Triton x-100
for 10 min at room temperature), immunofluorescence staining was performed
using the following antibodies: guinea pig anti-insulin (Dako, A0564) and goat
anti-GFP (Abcam, 6673). Images were taken on a Keyence BZ-X700 microscope
and images were analyzed using the BZ-X Advanced Analysis Software.
Oxidative stress measurement
For mouse islets, following stress treatment, 50-100 intact islets were transferred
to a polysterene round bottom tube and CellROX Deep Red Reagent (Invitrogen)
was added at 1:500 dilution to culture media followed by incubation at 37°C for
45 min. Islets were washed 2X with PBS, dispersed to single cell suspension,
attached to slides using cytospin, and imaged using fluorescence microscopy
(Keyence BZ-X700 microscope). GFP signal was used to identify transduced
cells and the CellROX signal from each cell was quantified and normalized by
cell area using BZ-X Advanced Analysis Software. Signal from at least 60 GFP
positive cells was assessed for each condition per experiment.
For Min6 cells, following stress treatment, CellROX Deep Red Reagent
(Invitrogen) was added at 1:500 dilution directly to culture media followed by
incubation at 37°C for 30 min. Cells were washed 2X with PBS and imaged using
fluorescence microscopy (Keyence BZ-X700 microscope). Bright field images
were used to determine cell areas and CellROX signal was quantified from at
least 6 imaging fields for each group using BZ-X Advanced Analysis Software.
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Caspase-3 and-7 activation assay
Following stress treatment, 50-100 intact islets were transferred to a polysterene
round bottom tube and fluorescent inhibitor of caspases (FLICA) reagent (ImageiT LIVE Red Caspase-3 and -7 Detect kit, Invitrogen) was added at 1:150 dilution
followed by incubation at 37°C for 1 hour. Islets were washed 2X with wash
buffer (provided by manufacturer), dispersed to single cell suspension, attached
to slides using cytospin, and imaged using fluorescence microscopy (Keyence
BZ-X700 microscope). Double positive cells were determined using BZ-X
Advanced Analysis Software, and at least 200 GFP positive cells were counted
for each condition per experiment.
RNA-seq and analysis
RNA was isolated using the RNeasy Mini Kit (Qiagen). Libraries were prepared
using NEB Next Ultra RNA Library Prep Kit according to manufacturer’s
instructions with polyA enrichment followed by paired-end sequencing of 150bp
using HiSeq (Illumina). Reads were mapped to mm10 using TopHat2 (Kim et al.,
2013) and read counts per gene were determined using featureCounts (Liao et
al., 2014). Differential expression analysis was performed using edgeR
(Robinson et al., 2010) with significant genes called using fold-change cutoffs of
greater than 1.5 or less than -1.5 and FDR less than 0.05. Gene ontology
analysis was performed using DAVID (Huang et al., 2009). The overlap between
RNA-seq data sets was determined using hypergeometric tests.
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Statistics
Data are presented as mean ± standard error of the mean unless otherwise
noted in figure legends. Statistical analyses were performed using GraphPad
PRISM 7 software. Statistical tests used are noted in figure legends and include
unpaired two-tailed Student’s t-test, one-way analysis of variance (ANOVA), twoway ANOVA, and hypergeometric test.
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Gender

Age

Race

BMI

Medical
History

HbA1c

Cold
ischemia
time (hr)

Cause of
death

Donor 1

F

39

Caucasian

34.8

Nondiabetic

4.7

8:33

Anoxia, drug
intoxication

Donor 2

M

24

Caucasian

20.8

Nondiabetic

4.9

16:27

Anoxia, drug
intoxication

Donor 3

F

31

Caucasian

32.7

Nondiabetic

4.4

9:59

Anoxia,
cardiovascular

Donor 4

M

23

unknown

-

Nondiabetic

5.3

-

Anoxia, drug
intoxication

Table 2. Human islet donor characteristics
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3.4 Results
3.4.1 Translational upregulation of JUND in β cells during metabolic stress
Our TRAP-seq results indicated that a subset of genes had increased ribosome
occupancy in Min6 cells with PDX1 deficiency despite no change in mRNA
abundance (Figure 2.2c). Of particular interest was the transcription factor JUND,
which is important for redox homeostasis in various cell types (Gerald et al.,
2004; Paneni et al., 2013). Given the particular vulnerability of β cells to oxidative
stress (Lenzen et al., 1996; Robertson et al., 2003), we hypothesized that JUND
plays an important, but as of yet unappreciated, role during the β cell stress
response.
We first investigated whether JUND upregulation extends to other stress
conditions with relevance for T2D pathophysiology. To this end, we exposed
mouse islets to a panel of stressors, including hydrogen peroxide (oxidative
stress), high levels of glucose and the free fatty acid palmitate, termed
glucolipotoxicity (metabolic stress), and thapsigargin (ER stress). While ATF4
was upregulated in all of these stress models, JUND was only induced by
metabolic stress (Figure 3.1a). Despite the increase in JUND protein levels
during glucolipotoxicity, there was no change in the abundance of JUND mRNA
(Figure 3.1b). This discordance could be caused by either an increase in the
translation of JUND mRNA or an increase in the stability of JUND protein. A
TRAP assay performed in GFP-RPL10A Min6 cells during metabolic stress
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showed a significant shift towards greater ribosome occupancy of the JUND
mRNA (Figure 3.1c), consistent with increased translation of JUND mRNA during
glucolipotoxicity. We next performed a cycloheximide chase assay in Min6 cells
and found no increase in JUND protein stability during glucolipotoxicity (Figure
3.1d,e). Furthermore, there was no difference in TUBULIN levels throughout the
time course between the two treatment groups, providing an additional control for
the experiment (Figure 3.1f). We also confirmed that there was a significant
induction of JUND protein levels at the 0hr time point (Figure 3.1g). Together,
these data indicate that JUND is translationally upregulated in β cells during
metabolic stress.
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Figure 3.1. JUND is translationally upregulated in β cells during metabolic stress.
a, Western blot depicting ATF4 and JUND levels in mouse islets treated with hydrogen peroxide
(H2O2, 200uM) for 1 hr, glucolipotoxicity (GLT, 25mM glucose, 500uM palmitate) for 2 days, or
thapsigargin (Tg, 1uM) for 3 hrs (n=3). b, Increased protein levels of JUND as determined by
Western blot, but not transcript levels by RT-qPCR, in mouse islets treated with glucolipotoxicity
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for 2 days (n=5). c, Increased ribosome occupancy of JUND in GFP-RPL10a Min6 cells after 30
hours of glucolipotoxic conditions, as determined by TRAP followed by RT-qPCR (n=3). d,
Representative western blot depicting reduction in JUND protein levels at indicated times after
addition of cycloheximide (CHX) to Min6 cells. CHX added after culturing for 30hrs in control or
glucolipotoxic (GLT) culturing conditions (n=3). e,f, Quantification of western blot signal for JUND
(e) or TUBULIN (f) normalized to RAN. Each group normalized to value at 0hr time point to depict
reduction in protein over time. g, Quantification of JUND western blot at 0hr time points with
normalization to the control group to depict increased JUND levels prior to CHX addition. P
values were calculated by unpaired two-tailed Student’s t-test, except in (e,f) in which a two-way
ANOVA was used. For Western blot images of JUND, arrows denote two bands for JUND and *
denotes a non-specific band. Otherwise, * = p < 0.05. Cont denotes control culturing conditions
and GLT denotes glucolipotoxic culturing conditions.
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To determine if this induction of JUND also occurs in β cells under metabolic
stress in vivo, we used 12-week-old db/db mice, which are obese with elevated
serum glucose and free fatty acid levels (Figure 3.2a-c). Indeed, compared to
non-diabetic db/+ mice, islets from db/db mice had a significant increase in JUND
protein, but not mRNA (Figure 3.2d). Thus, we have uncovered the posttranscriptional upregulation of JUND as a novel component of the β cell response
to metabolic stress.
To extend these findings to a human model, we assessed the induction of JUND
during metabolic stress by culturing human islets with high levels of glucose and
palmitate. Consistent with our findings in mouse islets, this excess of metabolic
fuel caused an increase in JUND protein levels in human islets (Figure 3.2e),
indicating that the induction of JUND during metabolic stress is conserved in
humans.
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Figure 3.2. Post-transcriptional induction of JUND in islets from db/db mice and in human
islets during metabolic stress.
a-c, Compared to age- and gender-matched db/+ mice, db/db male mice at 12-weeks of age had
increased body weight (a), blood glucose levels (b), and serum non-esterified fatty acid levels (c).
n = 3-4 per group. d, Western blot showing increased JUND levels in islets isolated from db/db
mice compared to db/+ at 12 wks of age. No change in JUND transcript as determined by RTqPCR (n=3). e, Representative Western blot showing increased JUND levels in human islets
treated with glucolipotoxic (GLT) conditions for 2 days. Quantification of results from four human
donors are shown. * = p < 0.05. P values were calculated by unpaired two-tailed Student’s t-test.
For Western blot images of JUND, arrows denote two bands for JUND and * denotes a nonspecific band. Otherwise, * = p < 0.05.
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3.4.2 β cell-specific depletion of JUND in primary islets
To study the function of JUND during metabolic stress, we developed a system
for β cell-specific depletion of JUND in isolated islets. To this end, we adopted a
protocol to allow for efficient transduction of primary islets with lentiviral
constructs (Jimenez-Moreno et al., 2015). Initial attempts to deplete genes using
lentiviral delivery of CRISPR-Cas9 were unsuccessful in primary mouse islets,
thus we decided to use an shRNA system. A lentiviral vector was constructed to
co-express GFP and an shRNA from the rat insulin promoter, and its functionality
was confirmed in Min6 cells (Figure 3.3a,b). Lentiviral transduction of intact
mouse islets was used to deliver shRNA constructs, followed by a recovery
period in culture media. To assess transduction efficiency, islets were dispersed
and assessed for GFP positivity by immunofluorescence staining. Nearly half of
all islet cells were GFP positive, and all GFP positive cells stained positive for
insulin, indicating efficient and β cell-specific transgene delivery (Figure 3.3c).
Further, the shRNA targeting JUND provided a 50% reduction in its transcript
level (Figure 3.3c), similar to the rate of transduction and suggesting a robust
depletion of JUND in those cells expressing the transgene.
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Figure 3.3. β cell-specific depletion of JUND in mouse islets via lentiviral delivery of
shRNA.
a, Schematic depicting shRNA system for β cell-specific depletion of JunD. b, Depletion of JunD
transcript in Min6 cells transduced with shRNA targeting JunD or non-targeting control (n = 5). c,
Immunofluorescence images showing β cell-specific expression of GFP in half of mouse islet
cells after lentiviral transduction. Arrows denote β cells staining positive for GFP. Delivery of
shRNA targeting JUND provides a significant reduction in JUND transcript compared to a nontargeting (NT) control (n=3-4). * = p < 0.05. Significance determined by unpaired two-tailed
Student’s t-test.
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3.4.3 Reduced oxidative stress in β cells with JUND depletion during
metabolic stress
Chronically elevated glucose and free fatty acid levels cause β cell dysfunction
and apoptosis at least partly due to increased oxidative stress (Piro et al., 2002;
Poitout and Robertson, 2008), but whether JUND contributes to β cell redox
homeostasis during metabolic stress is unknown. As expected, β cells exposed
to glucolipotoxicic conditions showed elevated oxidative stress as seen by
increased fluorescence from an oxidation-sensitive dye (Figure 3.4a,b). If JUND
were playing an antioxidant role in β cells, we predicted that there would be an
exacerbation of oxidative stress caused by glucolipotoxicity. Surprisingly,
however, depletion of JUND in β cells blocked the increase in oxidative stress
caused by high levels of glucose and palmitate (Figure 3.4a,b). This is in contrast
to findings in other cell types where loss of JUND leads to elevated reactive
oxygen species (ROS) levels (Gerald et al., 2004; Paneni et al., 2013),
highlighting the cell-type specificity of this factor. This prevention of redox
imbalance during metabolic stress was also observed in Min6 cells with CRISPRmediated depletion of JUND compared to a control group with a gRNA targeting
the ROSA26 locus (Figure 3.4c,d).
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Figure 3.4. β cell-specific depletion of JUND in mouse islets reduces oxidative stress
during glucolipotoxicity.
a,b, Assessment of oxidative stress in β cells transduced with shRNA vectors targeting JUND or
NT control by fluorescence imaging of CellROX Deep Red reagent. Whole mouse islets cultured
for 2 days in control or glucolipotoxic conditions prior to oxidative stress assessment.
Representative fluorescence image for GFP and CellROX in islet cells after cytospin and
frequency distribution of CellROX signal (a) and quantification of CellROX signal in GFP positive
cells (b). The frequency distribution of CellROX intensity is a representative finding and the
averages are for 3 independent experiments. c, Western blot showing depletion of JUND in Min6
cells using lentiviral delivery of CRISPR-Cas9. A gRNA targeting the ROSA26 locus is used as a
negative control. d, Quantification of CellROX signal in Min6 cells with CRISPR-mediated
depletion of JUND after culturing in glucolipotoxic conditions for 30hrs (n=4). P values were
calculated by two-way ANOVA. For Western blot images of JUND, arrows denote two bands for
JUND and * denotes a non-specific band. Otherwise, * = p < 0.05. Cont denotes control culturing
conditions and GLT denotes glucolipotoxic culturing conditions.
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3.4.4 Reduced apoptosis in β cells with JUND depletion during metabolic
stress
β cells are thought to be particularly sensitive to oxidative stress due to low
expression of antioxidant genes (Lenzen et al., 1996). Thus, we investigated
whether the impact of JUND on redox homeostasis would also affect β cell
apoptosis during metabolic stress. Using a fluorescence readout of caspase-3/7
activation, there was a 3-fold increase in the number of apoptotic β cells after
culturing islets with high levels of glucose and palmitate for 3 days (Figure 3.5a).
Consistent with its impact on redox imbalance, depletion of JUND significantly
reduced this induction of apoptosis during metabolic stress (Figure 3.5a). This
improvement in cell survival was confirmed in Min6 cells as CRISPR-mediated
depletion of JUND completely abrogated the increase in cleaved caspase-3
levels caused by metabolic stress (Figure 3.5b).
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Figure 3.5. β cell-specific depletion of JUND in mouse islets reduces apoptosis during
glucolipotoxicity.
a, Assessment of apoptosis in transduced β cells by fluorescence imaging of FLICA reagent,
which marks apoptotic cells as red, after 3 days of culturing mouse islets in control or
glucolipotoxic conditions. The percentage of GFP positive cells that were apoptotic were
averaged for 3 independent experiments. b, Western blot of cleaved caspase-3 used to assess
apoptosis in Min6 cells with CRISPR-mediated depletion of JUND and cultured in glucolipotoxic
conditions for 30hrs (n=3). P values were calculated by two-way ANOVA. For Western blot
images of JUND, arrows denote two bands for JUND and * denotes a non-specific band.
Otherwise, * = p < 0.05. Cont denotes control culturing conditions and GLT denotes glucolipotoxic
culturing conditions.
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3.4.5 JUND regulates pro-oxidant and pro-inflammatory genes in β cells
In accordance with the distinct pro-oxidant role of JUND in β cells, none of the
antioxidant genes reported to be targets of JUND in other cell types was
dysregulated in β cells (Figure 3.6a). This indicates that both the transcriptional
and phenotypic effects of JUND are cell-type specific. To investigate how JUND
impacts redox homeostasis and cell survival in β cells, we assessed the
transcriptome of Min6 cells cultured with high levels of glucose and palmitate
after CRISPR-mediated depletion of JUND, leading to the identification of 27
downregulated genes and 10 upregulated genes (Figure 3.6b). Gene ontology
analysis on the downregulated genes demonstrated a significant enrichment in
processes including stress response, ROS metabolism, and inflammation (Figure
3.6c). β cell-specific depletion of JUND in mouse islets confirmed most of these
genes to indeed be targets of JUND in primary β cells (Figure 3.6d). Interestingly,
several of these genes, including Nos2, Ptgs2, and Steap4, encode proteins with
enzymatic activity leading to ROS generation (Jin et al., 2015; Maciag, 2004;
Tabatabaie et al., 2003; Xia and Zweier, 1997; Zhou et al., 2013a). Thus, JUND
induction during metabolic stress likely contributes to β cell demise by activating
several deleterious genes, including pro-oxidants. Indeed, these JUND targets
were increased in mouse islets exposed to high levels of glucose and palmitate
(Figure 3.6e). Strikingly, nearly half of the genes downregulated with depletion of
JUND were previously identified via RNA-seq to be upregulated in islets from
diabetic db/db mice (Neelankal John et al., 2018) (Figure 3.6f), constituting a
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statistically significant overlap (Figure 3.6g, p = 6.0x10-5). The JUND target
genes also significantly overlapped with genes upregulated during PDX1
deficiency (Figure 2.2) or after treatment of human islets with palmitate (Cnop et
al., 2014) (Figure 3.6g). Together, these findings indicate that JUND regulates a
set of genes that are commonly increased in models of β cell dysfunction.
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Figure 3.6. JUND regulates pro-oxidant and pro-inflammatory genes associated with β cell
stress and dysfunction.
a, RT-qPCR analysis of mouse islets with shRNA-mediated depletion of JUND for panel of genes
reported to be downregulated with loss of JUND in denoted publications (n=3). b, Volcano plot
depicting changes in transcript levels after JUND depletion in Min6 cells cultured in glucolipotoxic
conditions for 30hrs, as determined by RNA-seq (n=3). Significant changes shown in red
(upregulated) or blue (downregulated). c, Gene ontology analysis for downregulated genes. d,
RT-qPCR panel of select JUND target genes in mouse islets with shRNA-mediated depletion of
JUND (n=3). e, Increased transcript levels of JUND target genes in mouse islets cultured for 2
days in glucolipotoxic (GLT) conditions (n=3). f, Heatmap of the genes downregulated after JUND
depletion with detectable expression in islets from db/db mice. The change in expression after
JUND depletion (JUND KO) is compared to the change in expression in islets from db/db vs db/+
mice. Genes with an asterisk had a statistically significant change in both data sets. g, The
significance of the overlap between gene sets is plotted. Genes downregulated after JUND
depletion are compared to genes upregulated in islets from db/db mice, with PDX1 depletion in
Min6 cells, or in human islets treated with palmitate (PA). P values were calculated by unpaired
two-tailed Student’s t-test (a,d,e) or hypergeometric tests (g). * = p < 0.05, unless otherwise
noted.
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3.5 Discussion
Oxidative stress has long been recognized as a major contributor to β cell
demise in T2D, thus new insights into the molecular mechanisms controlling
redox homeostasis in β cells are central to our understanding of diabetes
pathophysiology. Here, we have used a translation-centric approach to uncover
JUND as a stress-responsive gene and a novel regulator of β cell redox
homeostasis. JUND was upregulated in isolated mouse and human islets
exposed to metabolic stress, as well as islets from diabetic db/db mice, indicating
that this response is conserved across species and relevant for in vivo stress
conditions. In β cells, JUND depletion dampens oxidative stress caused by the
presence of excess metabolic fuel, which is in contrast to reports in other cell
types where loss of JUND enhances oxidative stress due to downregulation of
antioxidant genes (Gerald et al., 2004; Paneni et al., 2013). Although this
discrepancy was unexpected, the cell-type specific function of JUND is
consistent with its ability to dimerize with a variety of binding partners, which
likely shapes its tissue specific effects (Hai and Curran, 1991). Further, the
amelioration of ROS accumulation with JUND depletion agrees with our finding
that JUND positively regulates several genes with the capacity to increase ROS
production in β cells, including Ptgs2, Steap4, and Nos2, while having no impact
on the expression of antioxidant genes.
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It is unclear whether one or several of the identified JUND targets contribute to its
effect on oxidative stress and apoptosis in β cells. Interestingly, both Ptgs2 and
Steap4 are upregulated in islets from db/db mice and have some genetic
association with T2D in humans (Konheim and Wolford, 2003; Sharma et al.,
2015). Ptgs2, which encodes cyclooxygenase-2 (COX-2), imparts deleterious
effects in β cells, including impaired insulin secretion, reduced cell proliferation,
and increased free radical levels (Oshima et al., 2006; Persaud et al., 2007;
Tabatabaie et al., 2003). Steap4 encodes a metalloreductase involved in iron and
copper reduction (Scarl et al., 2017). While Steap4-/- mice develop hyperglycemia
likely due to adipose inflammation and insulin resistance (Wellen et al., 2007), its
function in β cells is unknown. In osteoclast differentiation and prostate
carcinogenesis, however, increased STEAP4 levels cause an elevation in cellular
ROS (Jin et al., 2015; Zhou et al., 2013a). Further, Nos2, or inducible nitric oxide
synthase (iNOS), has strong connections to cytokine-mediated β cell dysfunction
and death (Zumsteg et al., 2000).
Several other genes downregulated by JUND depletion are implicated in islet
inflammation, including Ccl2, Cxcl1, and Cxcl2, which have been linked to poor
outcomes for islet transplantation (Citro et al., 2012; Piemonti et al., 2002). Thus,
targeting JUND provides a new avenue for dampening oxidative stress and
inflammation in islets, which warrants further investigation for clinical applications
such as diabetes therapy and islet transplantation.
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The connection between these JUND target genes and β cell demise strengthens
our finding that JUND induction during glucolipotoxicity is maladaptive. Although
we initially expected the opposite outcome, the data presented here consistently
support this model. Furthermore, the significant overlap between JUND targets
and genes upregulated in islets from db/db mice indicates that the regulation of
these genes is relevant for in vivo stress conditions and is not an artifact of
culturing conditions. To follow-up on these studies, it would be ideal to
conditionally ablate JUND in β cell in vivo. However, this mouse model will need
to be carefully designed to avoid disrupting regulatory elements with loxP sites
since JUND is an intronless gene.
The discrepancy between JUND’s effect on oxidative stress in β cells compared
to endothelial cells or fibroblasts suggests that its interacting factors may also be
distinct between these cell types. The precise interacting factors that give rise to
these opposite phenotypes are currently unclear. Given the broad array of
hetero-dimers that can be formed with JUND, it may be difficult to pinpoint
exactly which combinations give rise to pro-oxidant or anti-oxidant effects.
The reported interaction between JUND and MENIN also raises the interesting
possibility that JUND could impact β cell proliferation (Agarwal et al., 1999). We
did not find any evidence that loss of JUND impacted cell cycle progression
based on our RNA-seq results. However, we did not directly assess proliferation
in our experiments. It should also be noted that the RNA-seq was performed in
Min6 cells, which are constantly in a proliferative state. Finally, JUND may
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regulate β cell proliferation only in the context of stress or particular
environmental conditions. Therefore, a closer examination of the impact of JUND
on β cell proliferation in primary islets, or ideally in vivo, is warranted.
Our results show for the first time that translational induction of JUND occurs in β
cells during metabolic stress conditions. To assess the conservation of this
finding in humans, we have shown a significant increase in JUND levels in
human islets cultured with high glucose and free fatty acid levels. This finding,
combined with the significant overlap between JunD targets and genes
upregulated during treatment of human islets with palmitate, indicates that JUND
induction is pertinent to the β cell response to metabolic stress in humans. To
expand on these findings, it would be interesting to examine whether there is an
increase in JUND levels in islets from individuals with T2D by
immunofluorescence staining. Given that the induction of JUND during in vitro
stress conditions is 2-3 fold and that there is typically high variability between
human samples, however, it may be difficult to confidently discern an increase in
JUND levels using this approach.
Given its effects on cell survival and oxidative stress, we propose a maladaptive
role for JUND in β cells under metabolic stress. These findings are based on
culturing islets under high glucose and palmitate levels comparable to that which
would be seen in late stages of T2D. Similarly, the in vivo assessment of JUND
induction utilized the db/db model at a stage of severe hyperglycemia. This is
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consistent with the notion that β cell apoptosis contributes to the worsening of
hyperglycemia at later stages of T2D rather than at the onset of the disease
(Prentki and Nolan, 2006). It is currently unclear whether JUND also influences β
cell function under milder stress conditions that would occur at earlier stages of
T2D.
Furthermore, one may contemplate why this maladaptive response occurs in β
cells under metabolic stress conditions. It is possible that this response is
adaptive under certain situations and becomes inappropriately activated under
prolonged disease conditions. Such a notion is particularly relevant for the
generation of ROS in cells. At low doses, ROS can act as critical signaling
molecules influencing a wide range of cellular processes, including insulin
secretion (Pi et al., 2007; Ray et al., 2012). When ROS accumulation becomes
excessive, however, these molecules become damaging. This imbalance, which
is the cause of oxidative stress, leads to impaired insulin secretion and increased
apoptosis in β cells (Poitout and Robertson, 2008). As such, it is possible that
JUND induction in the acute setting leads to constructive ROS generation and
activation of adaptive signaling pathways, whereas chronically it promotes β cell
demise.

	
  
100	
  
	
  

CHAPTER 4: AN ERK/HNRNPK/DDX3X AXIS POST-TRANSCRIPTIONALLY
REGULATES JUND DURING METABOLIC STRESS
4.1 Summary
Translational regulation is a critical component of stress responses, however, the
mechanisms controlling this process in pancreatic β cells during
pathophysiologically-relevant conditions are poorly understood. Here we show
that the translational induction of JUND during metabolic stress requires the RNA
binding protein hnRNPK. Furthermore, activation of the MEK/ERK signaling
pathway is both necessary and sufficient for phosphorylation of hnRNPK and
induction of JUND during glucolipotoxicity. Consistent with the effect of JUND on
β cell apoptosis, MEK inhibition significantly reduced cell death in mouse islets
during metabolic stress. The translational upregulation of JUND could not be
attributed to a change in hnRNPK subcellular localization, RNA binding affinity, or
nuclear retention of mRNA. Rather, we found that efficient JUND translation is
dependent on the RNA helicase DDX3X, an hnRNPK-interacting factor. During
glucolipotoxicity, there is increased interaction between DDX3X and the
translation pre-initiation complex (PIC), and this interaction is abrogated with loss
of hnRNPK. Thus, hnRNPK regulates JUND translation in part by facilitating the
recruitment of the PIC via DDX3X.	
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4.2 Introduction
In order to adapt to stress conditions imposed by changes in the extracellular
environment, β cells must dynamically shift their gene expression profile. This
allows for the synthesis of proteins that promote restoration of cellular
homeostasis and recovery from stress. On the other hand, changes in gene
expression can be maladaptive during disease states and exacerbate cellular
dysfunction. Therefore, the identification of factors that shape the β cell response
to stress conditions is a critical step towards better understanding the
mechanisms of β cell failure in T2D. In the previous chapters, we used a
translation-centric approach to uncover the transcription factor JUND as part of a
β cell maladaptive response to high levels of glucose and free fatty acids,
conditions relevant for T2D pathophysiology. Thus, understanding the
mechanisms controlling JUND translation during stress could provide novel
therapeutic strategies to modulate redox balance in β cells.
Translational regulation of specific mRNAs is dependent on the presence of
regulatory elements, typically in the 5’ or 3’ UTRs, which permit targeting by
sequence-specific factors, including microRNAs and RNA binding proteins
(RBPs). The enrichment of a poly(C) motif in genes from our TRAP screen
suggested this element may impart translational control mediated by the poly(C)binding protein family of RBPs.

102	
  
	
  

The PCBP family consists of five members (PCBP1-4 and hnRNPK), which play
diverse roles in gene regulation, including regulation of transcription, splicing,
alternative polyadenylation, mRNA stability, and translation (Bomsztyk et al.,
2004; Ji et al., 2013; 2016; Makeyev and Liebhaber, 2002; Ostareck-Lederer et
al., 2002; Waggoner et al., 2009). This diversity of function allows the PCBPs to
affect a broad array of cellular processes, including apoptosis, cell cycle
progression, cellular differentiation, etc. (Makeyev and Liebhaber, 2002;
Ostareck-Lederer and Ostareck, 2012; Waggoner et al., 2009). While the
members PCBP1-2 and hnRNPK are broadly expressed across cell types, they
may have cell-type specific effects based on the expression patterns of cofactors
and target mRNAs. Furthermore, a common mechanism for the functional
regulation of this family of RBPs is post-translational modification via
phosphorylation (Bomsztyk et al., 2004; Chaudhury et al., 2010b; Kimura et al.,
2010). This allows for the rapid integration of various signaling pathways with
multiple steps of gene expression. Thus, the PCBPs are fascinating candidates
for shaping the β cell gene expression profile in response to various stimuli and
stressors. Given their diversity of action, this regulation may be complex but
nevertheless deserves further scrutiny to uncover novel aspects of β cell biology.
In this chapter, we focus on the role of hnRNPK in regulating JUND translation in
β cells, leading to the identification of an ERK/hnRNPK/DDX3X pathway that is
activated during metabolic stress.
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4.3 Materials and Methods
Cell line culture
Min6 mouse insulinoma cells passage 20-30 were cultured in high glucose
DMEM as described (Claiborn et al., 2010), unless otherwise noted. For lentiviral
infections, Min6 cells were transduced for 6 hours with virus and polybrene
(Sigma) at 8ug/mL. Cells were allowed to recover for 4-5 days before collection
or stress treatments. HEK293T cells were cultured in DMEM containing 25mM
glucose.
Western blot
Proteins were separated by SDS-PAGE and immunoblotted with the following
antibodies: rabbit anti-JUND (Santa Cruz, sc-74), rabbit anti-hnRNPK (Bethyl
Laboratories, A300-674A), rabbit anti-DDX3X (Bethyl Laboratories, A300-474A),
rabbit anti-phospho-ERK1/2 (Cell Signaling, 4377), rabbit anti-total-ERK1/2 (Cell
Signaling, 4695), mouse anti-Tubulin (Sigma, T9026), and mouse anti-Ran (B.D.
610340).
Co-immunoprecipitation
Min6 cells were lysed in buffer containing 20mM Tris pH 8.0, 137 mM NaCl, 1mM
MgCl2, 1mM CaCl2, 1% NP-40, 10% glycerol, protease inhibitor cocktail
(Millipore), and Benzonase (Sigma) at 12.5 U/mL. Lysates were rotated at 4°C
for 1 hour. Protein concentration was determined using a Micro BCA Protein
Assay Kit (Thermo). 1ug of primary antibody was added to lysate encompassing
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500ug of protein and incubated overnight at 4°C. Protein A Dynabeads were
washed 3 times in lysis buffer then resuspended in lysate/antibody mixture and
incubated for 3 hours at 4°C. The immunoprecipitations were washed 4 times
with lysis buffer then eluted in NuPAGE LDS Sample Buffer (Invitrogen) by
heating at 70°C for 10 minutes. Eluted proteins and input samples were analyzed
by western blot.
Phos-tag analysis
Phos-tag was performed as described (Kinoshita et al., 2006). Briefly, lysates
were run on SDS-PAGE gels containing 25uM Phos-tag acrylamide (Wako),
50uM MnCl2, and 8% acrylamide. The gels were run for 4hrs at 90V to achieve
optimal separation of bands for hnRNPK. Prior to transfer, the gels were soaked
in buffer containing 10mM EDTA for 1 hour.
RNA immunoprecipitation
RNA immunoprecipitation was performed using rabbit anti-hnRNPK (Bethyl
Laboratories, A300-674A) or rabbit anti-DDX3X antibodies (Bethyl Laboratories,
A300-474A). hnRNPK or DDX3X antibodies or IgG were bound to Protein A
Dynabeads in buffer containing 20mM HEPES pH 7.4, 5mM MgCl2, 150mM KCl,
2mM DTT, 1% NP-40. Min6 cells were lysed in buffer containing 50mM Tris pH
8.0, 150mM NaCl, and 1% NP-40 with RNase, protease, and phosphatase
inhibitors. Total RNA was extracted from lysate (10% input) using RNeasy Mini
Kit (Qiagen). Lysate encompassing 75ug or 200ug of protein was added to beads
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bound to antibody for hnRNPK or DDX3X, respectively, and an IgG control, then
incubated overnight at 4°C. The next day, IPs were washed with buffer
containing 20mM HEPES pH 7.4, 5mM MgCl2, 350mM KCl, 2mM DTT, 1% NP40, and RNase inhibitors. RNA was eluted from beads in RLT buffer (Qiagen)
and RNA was isolated using RNeasy Mini Kit (Qiagen). For RIP followed by RTqPCR, enrichment was calculated by first normalizing transcript abundance in IP
RNA to that in total RNA and then to the IgG control.
CRISPR design and cloning
CRISPR gRNAs were designed using http://crispr.mit.edu/ to minimize off-target
binding (ROSA26: AAGATGGGCGGGAGTCTTCT, hnRNPK:
GTTTAATACTTACGTCTGTA, DHX9: TTCAGTTGTGATTATCCGAG and
GAGCGAGTTGCTTATGAGAG, DDX1: CAGATGAACCCATATGATAG and
GGAACTAGAGGACTGCTGAA, DDX3X: AGATTGGATACTGTTTACGA and
GCACCACCATAAACCACGCA). gRNAs were cloned into lentiCRISPR v2, as
described (Sanjana et al., 2014).
MEK1-CA Cloning
Constitutively active MEK1 fragments were generated by PCR with primers to
introduce S->D mutations at Ser218 and Ser222. CA-MEK1 and the rat insulin
promoter fragments were cloned into pLenti CMV blast (Campeau et al., 2009)
using Gibson Assembly (replaced CMV promoter with RIP).
Immunofluorescence staining of Min6 cells
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Min6 cells were cultured in 4-well chamber slides. After culturing under desired
conditions, cells were washed in PBS, and fixed for 15 minutes at room
temperature in 4% PFA. Following permeabilization (0.1% Triton x-100 for 10 min
at room temperature), immunofluorescence staining was performed using the
following antibodies: guinea pig anti-insulin (Dako, A0564) and goat anti-GFP
(Abcam, 6673). Images were taken on a Keyence BZ-X700 microscope and
images were analyzed using the BZ-X Advanced Analysis Software.
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4.4 Results
4.4.1 hnRNPK is required for the translational induction of JUND during
metabolic stress
Despite binding to its mRNA, loss of hnRNPK had no impact on JUND levels
under baseline conditions (Figures 2.4 and 2.6). Instead, we hypothesized that
hnRNPK controls the induction of JUND during metabolic stress. To assess this
possibility, we used CRISPR-Cas9 to deplete hnRNPK in Min6 cells followed by
treatment with high levels of palmitate. While control cells receiving a ROSA26
gRNA demonstrated the expected upregulation of JUND, depletion of hnRNPK
completely blocked this induction despite having no impact on JUND mRNA
abundance (Figure 4.1a,b). To confirm the specificity of this effect, we performed
a knockout/rescue experiment for hnRNPK in Min6 cells. The gRNA targeting
hnRNPK spans an intron-exon junction and thus should not affect vectormediated expression of hnRNPK due to the absence of introns. Indeed,
expression of hnRNPK from a lentiviral construct restored its expression in the
presence of the targeting gRNA (Figure 4.1c). While loss of hnRNPK prevented
JUND induction during glucolipotoxicity, re-expression of hnRNPK rescued this
effect comparable to the ROSA26 control group (Figure 4.1c). This indicates that
the impact of hnRNPK on JUND induction is not due to an off-target effect of
CRISPR editing. Thus, hnRNPK binds to the JUND mRNA and is required for its
post-transcriptional induction during metabolic stress.
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Figure 4.1. CRISPR-mediated depletion of hnRNPK blocks JUND induction during
glucolipotoxicity.
a, Western blot and quantification showing depletion of hnRNPK in Min6 cells using CRISPRCas9 and its impact on the induction of JUND after 2 days of palmitate treatment (n=6). b, No
change in JUND transcript levels with depletion of hnRNPK in Min6 cells during palmitate
treatment, as determined by RT-qpCR (n=6). c, Western blot and quantification showing
depletion of hnRNPK in Min6 cells using CRISPR-Cas9 and rescue with a vector to overexpress
hnRNPK. Cells were treated for 30hrs in control (Cont) or glucolipotoxic (GLT) conditions (n=2).
P values were calculated by two-way ANOVA (a) or unpaired two-tailed Student’s t-test (b). For
Western blot images of JUND, arrows denote two bands for JUND and * denotes a non-specific
band. Otherwise, * = p < 0.05.
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4.4.2 hnRNPK is phosphorylated during metabolic stress in a MEKdependent manner
A common mechanism for regulation of hnRNPK function is post-translational
modification via phosphorylation (Bomsztyk et al., 2004). To study changes in
hnRNPK phosphorylation, we used Phos-tag SDS-PAGE, which unveils
phosphorylated forms of hnRNPK via electrophoresis (Kimura et al., 2010). This
approach clearly demonstrated a shift towards increased phosphorylation of
hnRNPK in mouse islets or Min6 cells exposed to high levels of glucose and
palmitate while total hnRNPK levels did not change (Figure 4.2a,b). This increase
in phosphorylation was specific for metabolic stress, as it did not occur during
stress induced by hydrogen peroxide or thapsigargin, paralleling the pattern of
JUND induction (Figure 4.2c). Similarly, there was an increase in hnRNPK
phosphorylation in isolated islets from diabetic db/db mice, indicating that this
pathway is also activated during metabolic stress in vivo (Figure 4.2d). To assess
hnRNPK phosphorylation in a human model, we cultured human islets in
glucolipotoxic conditions and observed a significant increase in hnRNPK
phosphorylation by Phos-tag and no change in total hnRNPK levels (Figure
4.2e).
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Figure 4.2. Increased phosphorylation of hnRNPK during metabolic stress.
a, Phos-tag SDS-PAGE analysis shows changes in phosphorylation of hnRNPK in mouse islets
treated with glucolipotoxic (GLT) conditions for 2 days (n=5). b, Phos-tag SDS-PAGE and
Western blot showing increased phosphorylation of hnRNPK in Min6 cells treated with increasing
doses of palmitate for 2 days (n=3). c, Phos-tag for hnRNPK showing changes in phosphorylation
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in mouse islets treated with a panel of stressors including hydrogen peroxide (H2O2, 200uM) for 1
hr, GLT for 2 days, or thapsigargin (Tg, 1uM) for 3 hrs (n=3). d, Phos-tag SDS-PAGE analysis
shows changes in phosphorylation of hnRNPK in islets from 12-wk old db/db or db/+ male mice
(n=3). e, Phos-tag SDS-PAGE analysis shows changes in phosphorylation of hnRNPK in human
islets treated with glucolipotoxic (GLT) conditions for 2 days (n=3). np denotes band for nonphosphorylated hnRNPK and ph denotes bands for phosphorylated hnRNPK. P values were
calculated by unpaired two-tailed Student’s t-test. For Western blot images of JUND, arrows
denote two bands for JUND and * denotes a non-specific band. Otherwise, * = p < 0.05.
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To assess whether this increase in phosphorylation is unique to hnRNPK or
common amongst PCBP family members, we performed Phos-tag analysis for
PCBP1 and PCBP2 in Min6 cells exposed to metabolic stress conditions.
Compared to analysis using standard SDS-PAGE, Phos-tag revealed additional
bands for PCPB1 and PCBP2 correlating to phosphorylated forms of these
proteins (Figure 4.3). However, unlike hnRNPK, there was no obvious change in
the relative pattern nor intensity of these bands in Min6 cells exposed to high
palmitate levels (Figure 4.3). This suggests that the increase in phosphorylation
during metabolic stress is unique to hnRNPK and does not occur for PCBP1/2.
However, Phos-tag analyses may not resolve all phosphorylated sites of a
particular protein (Kinoshita et al., 2008), thus we cannot rule out the possibility
that there is an increase in phosphorylation of PCBP1/2 at a site that cannot be
identified by Phos-tag.
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Figure 4.3. No change in phosphorylation of PCBP1/2 during metabolic stress as detected
by Phos-tag analysis.
Phos-tag SDS-PAGE and Western blot showing no change in phosphorylation or total protein
levels of PCBP1/2 in Min6 cells treated with indicated concentration of palmitate for 24 hours
(n=3).
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One of the kinase cascades that targets hnRNPK and modulates its function is
the MEK/ERK signaling pathway (Habelhah et al., 2001), which was activated in
mouse islets treated with high levels of glucose and palmitate (Figure 4.4a).
Treatment of mouse islets with the potent and specific MEK1/2 inhibitor
trametinib during metabolic stress completely abolished p-ERK1/2 levels while
also blocking the increase in phosphorylation of hnRNPK and the induction of
JUND (Figure 4.4a). Trametinib treatment also reduced expression levels of most
JUND target genes in mouse islets, including Ptgs2 and Steap4 (Figure 4.4b). To
test the sufficiency of ERK to activate the hnRNPK/JUND axis, we
overexpressed a constitutively active form of MEK1 (S218/222D) in Min6 cells.
As expected, this led to a robust increase in phosphorylation of ERK1/2 (Figure
4.5a). Consistent with the effect of MEK inhibition, expression of constitutively
active MEK1 was sufficient to increase JUND levels, hnRNPK phosphorylation,
and expression of many JUND targets, most notably Ptgs2 (Figure 4.5a,b). To
test whether blocking the hnRNPK/JUND axis via MEK inhibition would also
reduce apoptosis, we assessed caspase activation in mouse islets treated with
trametinib and found a striking decrease in apoptosis during metabolic stress
(Figure 4.6).
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Figure 4.4. MEK inhibition blocks hnRNPK phosphorylation and JUND induction during
metabolic stress.
a,b Western blot, Phos-tag SDS-PAGE (a), and RT-qPCR (b) analyses show that trametinib
treatment (1uM) blocks ERK phosphorylation and activation of the hnRNPK/JUND axis in mouse
islets cultured for 2 days in glucolipotoxic (GLT) or control conditions. Quantification is the
average of 4 (a) or 3 (b) biological replicates. * = p < 0.05. P values were calculated by two-way
ANOVA (a) or unpaired two-tailed Student’s t-test (b). For Western blot images of JUND, arrows
denote two bands for JUND and * denotes a non-specific band. Otherwise, * = p < 0.05.
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Figure 4.5. Overexpression of constitutively active MEK1 in Min6 cells is sufficient to
activate the hnRNPK/JUND axis.
a,b Lentiviral overexpression of constitutively active (CA) MEK1 (S218/222D) in Min6 cells
activates the ERK/hnRNPK/JUND pathway as determined by Western blot and Phos-tag SDSPAGE (a) or RT-qPCR (b) (n=3). EV denotes lentiviral transduction with empty vector. * = p <
0.05. P values were calculated by unpaired two-tailed Student’s t-test. For Western blot images of
JUND, arrows denote two bands for JUND and * denotes a non-specific band. Otherwise, * = p <
0.05.
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Figure 4.6. MEK inhibition reduces islet cell apoptosis during glucolipotoxicity.
Trametinib treatment (1uM) reduces the percentage of apoptotic cells, as determined by
fluorescence imaging of FLICA reagent, in mouse islets cultured for 3 days in GLT conditions
(n=3). * = p < 0.05. P values were calculated by two-way ANOVA.
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4.4.3 No change in hnRNPK localization, RNA binding affinity, or nuclear
retention of RNA during metabolic stress
To further investigate how hnRNPK may impact JUND translation during
metabolic stress, we considered several possible mechanisms based on
modifiable properties of hnRNPK. For example, hnRNPK is a nucleo-cytoplasmic
shuttling protein and its subcellular distribution can vary amongst cell types
(Bomsztyk et al., 2004). Furthermore, this property of hnRNPK is dynamic and
can be modified by its phosphorylation state. Indeed, it has been reported that
phosphorylation of hnRNPK by ERK leads to its cytoplasmic accumulation in
HeLa cells (Habelhah et al., 2001). To assess whether phosphorylation of
hnRNPK during glucolipotoxicity also influenced the subcellular distribution of
hnRNPK, we performed immunofluorescence staining of Min6 cells. First, we
confirmed the specificity of the hnRNPK antibody in immunostaining analyses by
showing that CRISPR-mediated depletion of hnRNPK in Min6 cells leads to the
complete loss of the immunofluorescence signal in the targeted cells (Figure
4.7a). Next, we assessed the subcellular localization of hnRNPK in Min6 cells
treated with glucolipotoxicity and observed no change in its distribution compared
to control conditions (Figure 4.7b). Given the reported connection between
hnRNPK localization and ERK signaling, we further investigated this possibility
by using overexpression of constitutively active MEK1, which leads to robust
phosphorylation of ERK1/2 (Figure 4.5). In contrast to previous reports,
expression of constitutively active MEK1 had no impact on hnRNPK subcellular
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distribution (Figure 4.7c). Together, these results indicate that the impact of
hnRNPK on JUND translation during glucolipotoxicity cannot be explained by a
change in its nucleo-cytoplasmic shuttling.
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Figure 4.7. No change in hnRNPK subcellular distribution in Min6 cells during metabolic
stress.
a, Representative immunofluorescence images of fixed Min6 cells with CRISPR-mediated
depletion of hnRNPK in a subset of cells to confirm the specificity of the hnRNPK antibody. A
gRNA targeting the ROSA26 locus was used as a negative control. b,c, Representative
immunofluorescence images of fixed Min6 cells that were treated with control or glucolipotoxic
conditions for 30hrs (b) or transduced with lentivirus to overexpress constitutively active MEK1
(CA-MEK1) (c), which show no detectable change in the subcellular localization of hnRNPK
under these conditions.
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Another modifiable property of hnRNPK is its RNA binding affinity. For example,
treatment of a rat hepatoma cell line with insulin led to phosphorylation of
hnRNPK, and this increased the binding affinity of hnRNPK for RNA containing
poly(C) stretches (Ostrowski et al., 2001). Therefore, we hypothesized that
phosphorylation of hnRNPK during glucolipotoxicity affected JUND translation by
increasing the interaction between hnRNPK and the mRNA encoding JUND. To
assess this possibility, we performed RNA immunoprecipitation for hnRNPK in
Min6 cells treated with control or glucolipotoxic conditions. This showed that
there was no change in the amount of JUND mRNA pulled down with hnRNPK in
the RIP experiment, suggesting that a change in hnRNPK binding to JUND
mRNA cannot explain its effect on translation (Figure 4.8a).
The export of mRNA from the nucleus to the cytoplasm can be regulated to
provide an additional post-transcriptional control on gene expression. In fact,
some mRNAs are preferentially retained in the nucleus, and this has recently
been attributed at least in part to targeting by hnRNPK (Lubelsky and Ulitsky,
2018). Therefore, we next considered the possibility that hnRNPK regulates the
nuclear retention of JUND mRNA in a stress-dependent manner. To address this,
we first investigated whether there is a shift in the nucleo-cytoplasmic localization
of the JUND mRNA during metabolic stress. We performed fractionation
experiments in Min6 cells to enrich for nuclear and cytoplasmic compartments
and isolated RNA from these pools. To validate our methodology of fractionation,
we assessed the nuclear/cytoplasmic distribution of genes with known
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localization patterns. For example, mRNAs encoding housekeeping factors, such
as HPRT and BETA-ACTIN are highly translated and should be predominantly
cytoplasmic. In agreement with this, approximately 80% of the mRNA for these
genes was located in the cytoplasmic fraction (Figure 4.8b). On the other hand,
NEAT1 is a nuclear enriched long non-coding RNA, and accordingly 90% of its
mRNA was present in the nuclear fraction. As an additional nuclear control, we
used primers spanning an intron-exon junction for PDX1 to detect its primary
transcript, which should be found in the nucleus. Indeed, 85% of this mRNA was
located in the nuclear compartment. Assessment of JUND mRNA showed that is
was predominantly located in the cytoplasm, and there was no change in its
localization during glucolipotoxicity (Figure 4.8b). Thus, a shift in the nucleocytoplasmic distribution of the JUND mRNA cannot explain its induction during
metabolic stress.
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Figure 4.8. No change in hnRNPK RNA binding affinity or nuclear retention of mRNA
during metabolic stress.
a, No change in the interaction of hnRNPK with the mRNA encoding JUND in Min6 cells after
30hrs treatment with glucolipotoxicity (GLT), as determined by RNA immunoprecipitation (n=4). b,
Fractionation of Min6 cells into nuclear and cytoplasmic pools followed by RT-qPCR analysis
shows no change in the subcellular localization of the JUND mRNA after culturing for 30hrs in
GLT conditions (n=2). Transcript level in the cytoplasmic fraction was normalized to the combined
transcript level in the cytoplasmic and nuclear fractions to determine the fraction of mRNA in the
cytoplasm. HPRT and BETA-ACTIN were used as controls for cytoplasmic enriched RNA while
NEAT1 and PDX1 primary transcript (PT) were used as controls for nuclear enriched RNA to
assess fractionation quality. P values were calculated by unpaired two-tailed Student’s t-test.
Cont denotes control culturing conditions and GLT denotes glucolipotoxic culturing conditions.
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4.4.4 DDX3X interacts with hnRNPK and is required for efficient translation
of JUND mRNA
Since we were unable to detect a change in some of the known modifiable
properties of hnRNPK during metabolic stress (Figures 4.7 and 4.8), we
hypothesized that hnRNPK impacts JUND translation via a binding partner. The
JUND mRNA contains a highly structured 5’UTR (Short and Pfarr, 2002), and
efficient translation initiation is dependent on RNA helicases, such as DHX9, to
resolve these secondary structures (Hartman et al., 2006). Upon searching mass
spectrometry data sets for hnRNPK interacting factors (Chen et al., 2002; Mikula
et al., 2015), we noticed the presence of the DEAD-box helicases DHX9, DDX1,
and DDX3X in the hnRNPK interactome. Given the connection of DEAD-box
helicases to the regulation of translation (Hartman et al., 2006; Linder and
Jankowsky, 2011), we depleted these genes in Min6 cells via CRISPR-Cas9 to
determine their impact on JUND induction during metabolic stress (Figure
4.9a,b). Interestingly, loss of DDX3X, but not DHX9 nor DDX1, led to reduced
JUND protein levels in Min6 cells during glucolipotoxicity (Figure 4.9c). On the
other hand, loss of DDX3X also led to a significant increase in JUND mRNA
levels (Figure 4.9d). This decrease in the amount of JUND protein despite an
increase in mRNA abundance likely signifies a defect in translation initiation
caused by loss of DDX3X, consistent with its ability to enhance translation of
select mRNAs (Soto-Rifo et al., 2012). Indeed, depletion of DDX3X in GFPRPL10A Min6 cells led to a significant reduction in the density of ribosomes
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binding to the JUND mRNA, as determined by TRAP (Figure 4.9e). These data
indicate that DDX3X is required for the efficient translation of JUND mRNA.
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Figure 4.9. DDX3X is required for the efficient translation of JUND mRNA.
a,b RT-qPCR for DHX9, DDX1, and DDX3X (a) and Western blot for DDX3X (b) show a
significant depletion of these RNA helicases using CRISPR-Cas9 in Min6 cells (n=3). c,
Representative western blot depicting JUND levels in Min6 cells transduced with lentivirus to
deplete the indicated RNA helicase using CRISPR-Cas9 and cultured in glucolipotoxic conditions
for 30hrs (n=3). d, Assessment of JUND mRNA abundance in Min6 cells by RT-qPCR after
CRISPR-mediated depletion of DDX3X and culturing in glucolipotoxic conditions for 30hrs (n=3).
e, Decreased ribosome occupancy of JUND in GFP-RPL10a Min6 cells after depletion of DDX3X
by CRISPR-Cas9 and 30 hours of glucolipotoxic conditions, as determined by TRAP followed by
RT-qPCR (n=3). * = p < 0.05 and ns = not significant. P values were calculated by two-way
ANOVA except in (b) in which an unpaired two-tailed Student’s t-tests was used. In (d) * denotes
significance compared to ROSA26 group of the same treatment. For Western blot images of
JUND, arrows denote two bands for JUND and * denotes a non-specific band. Otherwise, * = p <
0.05.
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To assess the interaction between hnRNPK and DDX3X, we performed coimmunoprecipitation experiments in Min6 cells in the presence of a nuclease to
degrade both RNA and DNA. This showed a clear nucleic acid-independent
interaction between these two factors that was maintained during
glucolipotoxicity (Figure 4-10a). DDX3X and its yeast homolog Ded1 can impact
translation through interaction with components of the translation pre-initiation
complex (PIC), especially the 18S ribosomal RNA (Guenther et al., 2018; Oh et
al., 2016). Indeed, RIP for DDX3X showed a robust binding to 18S in Min6 cells,
and this interaction was increased during metabolic stress (Figure 4-10b).
Intriguingly, CRISPR-mediated depletion of hnRNPK in Min6 cells significantly
reduced the association between DDX3X and 18S (Figure 4-10c). DDX3X has
been reported to bind to all expressed mRNAs, likely via its interaction with the
PIC (Guenther et al., 2018; Oh et al., 2016). Consistent with this, DDX3X bound
to all analyzed mRNAs by RIP, and these interactions were significantly reduced
with loss of hnRNPK (Figure 4-10d). These data support a model whereby
hnRNPK impacts translation in part by promoting the interaction between DDX3X
and the PIC. Thus, we have identified DDX3X as a novel regulator of JUND
translation during metabolic stress that interacts with the 18S ribosomal RNA in
an hnRNPK-dependent manner.
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Figure 4.10. DDX3X interacts with the 18S ribosomal RNA in an hnRNPK-dependent
manner.
a, Western blots from pull-down of hnRNPK (left) or DDX3X (right) in Min6 cells treated with
glucolipotoxic conditions for 30 hrs. b,c RNA immunoprecipitation for DDX3X followed by RTqPCR for 18S ribosomal RNA in Min6 cells treated with glucolipotoxic conditions for 30hrs (n=3)
(b) and in Min6 cells with CRISPR-mediated depletion of hnRNPK and cultured in glucolipotoxic
conditions for 30hrs (n=3) (c). d, Decreased interaction between DDX3X and indicated mRNAs
after CRISPR-mediated depletion of hnRNPK in Min6 cells treated with glucolipotoxic conditions
for 30hrs as determined by RNA immunoprecipitation for DDX3X (n=3). * = p < 0.05 and ns = not
significant. P values were calculated by two-way ANOVA except in (b) in which unpaired twotailed Student’s t-tests were used. In (c,d), * denotes significance compared to ROSA26 group of
the same treatment unless otherwise noted. For Western blot images of JUND, arrows denote
two bands for JUND and * denotes a non-specific band. Otherwise, * = p < 0.05.
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4.5 Discussion
Although the transcriptional regulators that shape the proper β cell gene
expression program have received much attention, the factors important for posttranscriptional regulation in β cells, such as RBPs, are less defined but may be
critical for adaptation to environmental stressors. Here, an unbiased search for
putative regulatory motifs led to the identification of hnRNPK as a posttranscriptional regulator of JUND expression. While we implicate hnRNPK as a
regulator of translation in β cells, its highly multi-functional nature suggests it
likely serves other roles as well, such as regulating transcription, splicing, and
mRNA stability (Bomsztyk et al., 2004). This versatility is intriguing in that
hnRNPK can integrate signaling pathways with multiple aspects of RNA
processing, but it also complicates the design and interpretation of loss-offunction studies. Nevertheless, given its activation during metabolic stress in
vivo, a systematic analysis of hnRNPK function holds promise to elucidate novel
aspects of β cell biology. By focusing on hnRNPK interacting factors, we
identified the RNA helicase DDX3X as a novel hnRNPK partner that participates
in the regulation of JUND translation. While the function of DDX3X in β cells is
unknown, its links to cell cycle progression, apoptosis, and innate immunity in
other cell types (Ariumi, 2014) warrant a broader examination of DDX3X function
in β cells.
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hnRNPK can be phosphorylated downstream of multiple signaling pathways,
including Protein kinase C, JNK, and ERK (Habelhah et al., 2001; Schullery et
al., 1999). In β cells, we have found that activation of the MEK/ERK signaling
pathway is both necessary and sufficient to increase hnRNPK phosphorylation
and induce JUND levels (Figure 4.11). Furthermore, in the context of metabolic
stress, inhibition of this ERK/hnRNPK/JUND axis with trametinib reduced
apoptosis in mouse islets. This is consistent with previous findings that MEK
inhibition reduced apoptosis in human islets treated with high glucose levels or
IL-1β (Maedler et al., 2004). In contrast, activation of the MEK/ERK signaling
pathway has been shown to promote β cell survival in the context of incretin
signaling (Campbell et al., 2016; Quoyer et al., 2010). Thus, the impact of MEK
inhibition on β cell viability is context-dependent. Interestingly, treatment of ob/ob
mice with trametinib improves glucose homeostasis in these animals, however,
this effect appears to be largely attributable to an improvement in insulin
sensitivity (Banks et al., 2015). Thus, the use of MEK inhibition in metabolic
syndrome warrants further investigation for improving both insulin sensitivity and
β cell viability.
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Figure 4.11. Model diagram depicting an ERK/hnRNPK/JUND axis that promotes oxidative
stress and apoptosis in β cells.
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To advance our understanding of translational regulation mediated by hnRNPK,
we systematically evaluated modifiable properties of hnRNPK during metabolic
stress including its subcellular localization, RNA binding affinity, and nuclear
retention of mRNA. None of these features, however, could explain the induction
of JUND during glucolipotoxicity. This led us to consider the possibility that
hnRNPK regulates translation via a cofactor. To further explore this prospect, we
utilized published mass spectrometry data sets for hnRNPK interacting factors
(Chen et al., 2002; Mikula et al., 2015), however, this included nearly 200
proteins. Accordingly, we focused our search on RNA helicases because JUND
has been reported to contain a highly structured 5’UTR (Short and Pfarr, 2002),
which narrowed our search to three candidates: DHX9, DDX1, and DDX3X.
DHX9 has previously been shown to regulate JUND translation in COS cells
(Hartman et al., 2006) and it was highly enriched for hnRNPK binding in one
mass spectrometry data set (Mikula et al., 2015); therefore this target seemed
particularly promising. Surprisingly, however, depletion of DHX9 had no impact
on the induction of JUND during glucolipotoxicity or on its expression under
baseline conditions in Min6 cells. One possibility is that other DEAD-box
helicases expressed in β cells provide redundancy for DHX9. Indeed, the DEADbox protein family contains 37 members in humans, many of which regulate
translation (Linder and Jankowsky, 2011).
In contrast to DHX9, loss of DDX3X clearly reduced JUND translation in Min6
cells based on reductions in both protein levels and ribosome occupancy. In
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other cell types, DDX3X has been implicated in translational regulation of specific
mRNAs, such as cyclin E1 (Lai et al., 2010), and several viral genes (ie: HIV,
Japanese encephalitis virus, etc.) (Soto-Rifo et al., 2012). In Min6 cells, DDX3X
depletion significantly reduced the ribosome occupancy of JUND, but not BETAACTIN, mRNA, indicating that loss of DDX3X impacts the translation of specific
genes. In the future, it would be interesting to define the full catalog of DDX3X
targets in β cells by TRAP-seq. Additionally, we cannot rule out the possibility
that loss of DDX3X also has an effect on global translation rates, which would not
be picked up by TRAP analyses.
We also investigated the mechanism by which DDX3X and hnRNPK may
cooperate to impact translation. Under metabolic stress, increased
phosphorylation of hnRNPK does not change its binding to the JUND mRNA.
Instead, we considered the possibility that phosphorylation of hnRNPK may
enhance its interaction with DDX3X, thus recruiting the helicase to JUND mRNA
in a stress-dependent manner. However, co-immunoprecipitation experiments
showed no change in the interaction between these factors under control versus
glucolipotoxic conditions (Figure 4.10).
The mechanisms by which RNA helicases impact translation of specific mRNAs
include remodeling secondary structures in the 5’UTR and recruitment of the
translation pre-initiation complex (PIC) (Marintchev, 2013). DDX3X has been
shown to directly bind to the 18S ribosomal RNA, a component of the PIC (Oh et
al., 2016). This led us to hypothesize that hnRNPK may impact the interaction
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between DDX3X and the PIC. Interestingly, during metabolic stress, there was
increased interaction between DDX3X and the 18S ribosomal RNA, and this
interaction was significantly reduced in Min6 cells with loss of hnRNPK. This
suggests that hnRNPK may influence translation in part by facilitating recruitment
of the PIC via DDX3X. It is unclear how hnRNPK impacts the DDX3X-PIC
interaction. One possibility is that hnRNPK promotes formation of the complex by
directly recruiting the PIC in a stress-dependent manner. On the other hand,
hnRNPK could indirectly facilitate this interaction via assembly of a larger
complex that includes DDX3X and the PIC, and the composition of this complex
may be altered during metabolic stress in an hnRNPK- and ERK-dependent
manner (Figure 4.12). Additionally, this complex may contain cofactors that
modulate DDX3X activity, as has been reported for EZRIN and GLE1 (Bolger
and Wente, 2011; Çelik et al., 2015). Thus, it would be interesting to more
comprehensively define the hnRNPK and DDX3X interactome in β cells under
control and glucolipotoxic conditions to identify other components of this
hnRNPK-DDX3X complex, and to determine whether they are recruited in a
stress-dependent manner.
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Figure 4.12. Model diagram depicting recruitment of the PIC by an hnRNPK-DDX3X
complex during metabolic stress.
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Another mechanistic detail that deserves further elaboration is the localization of
the DDX3X-hnRNPK complex on mRNA. Our de novo motif analysis and the
eCLIP data for hnRNPK indicate that it binds to the 3’UTR of the JUND mRNA.
DDX3X, on the other hand, has been reported to predominantly bind to the
5’UTR of genes (Oh et al., 2016). Therefore, one possibility is that the interaction
occurs while DDX3X and hnRNPK are bound to the 5’ and 3’ UTR, respectively,
thus facilitating circularization of the JUND mRNA (Figure 4.11) similar to that
mediated by PABP and eIF4G to promote efficient translation initiation
(Kahvejian et al., 2005). Interestingly, another binding partner for DDX3X is
PABP (Soto-Rifo et al., 2012), however, it is unclear if this factor is part of the
hnRNPK-DDX3X complex. Circularization of mRNA has been proposed to
stimulate ribosome recycling (Dever and Green, 2012), thus it is enticing to
speculate that hnRNPK could promote the re-assembly of initiation complexes
after termination. Another possibility is that the hnRNPK-DDX3X interaction
occurs independent of their respective binding to RNA. In this situation, hnRNPK
may prime a translation initiation complex by facilitating the interaction between
DDX3X and the PIC prior to loading onto mRNA.
Translation initiation can occur independent of binding to the 5’ cap, and this
mode of translation initiation is particularly important during certain stress
conditions due to sequestration of eIF4E (Spriggs et al., 2010). It is unclear
whether translation initiation regulated by the DDX3X-hnRNPK complex can
occur independent of binding to the 5’ cap. Interestingly, hnRNPK mediates
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translation initiation at some cellular IRESs, such as in the 5’UTR of c-myc
(Evans et al., 2003). Similarly, DDX3X is critical for translation initiation at several
viral IRESs, including that of hepatitis C virus (Geissler et al., 2012). Thus, it will
be interesting to examine whether this complex functions during capindependent conditions to enhance JUND translation.
It has recently been shown that loss of Ded1, the yeast homolog of DDX3X,
promotes alternative start codon usage in the 5’ UTR of certain genes (Guenther
et al., 2018). Intriguingly, close examination of western blots for JUND indicates
the appearance of an additional faint band after depletion of DDX3X (Figure
4.9c). One possibility is that DDX3X prevents the inappropriate translation
initiation at alternative start codons in the 5’UTR of JUND. The mapping of
translation initiation sites can be achieved using ribosome profiling after
treatment of cells with the drug harringtonine to freeze ribosomes at sites of
initiation (Ingolia et al., 2011). This approach could be used to determine if loss of
DDX3X dysregulated start codon usage in β cells on a genome-wide scale. This
would be particularly interesting to assess in β cells because it has been
suggested that translation from an alternative initiation site in the insulin mRNA
produces an immunogenic peptide that may contribute to the development of
type 1 diabetes (Kracht et al., 2017).
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CHAPTER 5: CONCLUDING REMARKS AND FUTURE DIRECTIONS
5.1 Discussion of key findings
The dysfunction and apoptosis of pancreatic β cells are central to the progression
of T2D, thus identifying new strategies to ameliorate these processes holds
promise to reduce the burden of this chronic disease. In this work, I have
approached this goal by first studying the mechanisms underlying β cell
adaptation to stress conditions that are pertinent to diabetes. By focusing on
translational regulation, I uncovered a novel ERK/hnRNPK/JUND axis that is
activated during metabolic stress. There were several advantages to the
translation-centric approach used in these studies. First, the translational
induction of JUND was not accompanied by an increase in mRNA abundance,
therefore examining the transcriptome would not have identified JUND as a
stress-responsive factor. Second, assessing translational regulation on a
genome-wide scale with TRAP-seq allowed me to probe for upstream regulators
of translation by searching for common features of genes with changes in
ribosome occupancy. This led to the identification of a poly(C) motif that was
enriched in 3’UTRs, which implicated the PCBP family members in posttranscriptional regulation in β cells.
The initial TRAP screen led me to investigate the role of JUND in β cells. Given
its previous link to regulating antioxidant genes, I hypothesized that JUND
induction during metabolic stress was a protective mechanism, and that loss of
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JUND would exacerbate ROS accumulation. Surprisingly, however, I found the
opposite effect: depletion of JUND blocked the increase in oxidative stress during
glucolipotoxicity.
As a transcription factor, the role of JUND in a particular cell type is completely
dependent on the cohort of genes it regulates. Consistent with its effect on
oxidative stress, loss of JUND in β cells led to the downregulation of pro-oxidant,
rather than anti-oxidant genes. The mechanism underlying this cell type-specific
role for JUND is likely related to its array of interacting factors. JUND binds to
DNA as a homo- or hetero-dimer with other members of the Jun transcription
factor family or with members of the Fos, Atf, and Maf transcription factor
families, and the composition of these dimers will dictate the DNA binding
preference and transcriptional effect of JUND (Mechta-Grigoriou et al., 2001).
Thus, the discrepancy in transcriptional targets between cell types may be
attributable to the relative expression of JUND binding partners.
Furthermore, I used RNA-seq to perform an unbiased search for JUND targets,
which led to the identification of a relatively small cohort of genes, many of which
have been implicated in ROS production and inflammation. Strikingly, this set of
genes significantly overlapped with genes upregulated in various models of β cell
dysfunction, including islets from db/db mice, human islets treated with palmitate,
and Min6 cells with PDX1 deficiency. This supports a model in which JUND
regulates genes implicated in β cell dysfunction and suggests my findings may
be generalizable and not specific to the model of glucolipotoxicity.
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Lastly, if JUND were playing an antioxidant role in β cells, as has been
suggested in other cell types, one would predict an exacerbation of stressinduced cell death with loss of JUND because β cells are particularly sensitive to
oxidative stress (Lenzen et al., 1996). Instead, I observed that depletion of JUND
in β cells significantly blunted apoptosis during metabolic stress, consistent with
the proposed pro-oxidant role for JUND. Collectively, these results significantly
strengthen the novel finding that JUND has a maladaptive function in β cells by
promoting oxidative stress.
I also identified the MEK/ERK signaling pathway as being necessary and
sufficient to activate the hnRNPK/JUND pathway in β cells. Given the proapoptotic role ascribed to JUND during metabolic stress, I investigated whether
blocking JUND induction via MEK inhibition would also improve cell viability and
found a striking reduction in apoptosis during glucolipotoxicity. While this result is
consistent with the effect of JUND depletion on apoptosis, it is unclear to what
extent the benefit of MEK inhibition can be attributed to reduced JUND levels.
Inhibition of the MEK/ERK signaling pathway will have broad effects on the cell,
therefore it is very likely that other downstream targets also contribute to this
phenotype. For example, ERK-mediated upregulation of p53 has been found to
increase levels of pro-apoptotic factors, such as BAX (Cagnol and Chambard,
2009).
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Given these pro-oxidant and pro-apoptotic roles for JUND in β cells, I reasoned
that advancing our mechanistic understanding of JUND induction could provide
new targets for diabetes therapy. To this end, I utilized publicly available data
sets of hnRNPK interacting factors to identify candidate cofactors, leading to the
discovery that the RNA helicase DDX3X is required for efficient JUND
translation. This factor can impact translation via its ATP-dependent helicase
activity or by recruiting components of the translation pre-initiation complex (PIC)
(Marintchev, 2013). Interestingly, there was increased interaction between
DDX3X and the 18S ribosomal RNA, a component of the PIC, during metabolic
stress. This indicates that the function of DDX3X is regulated during
glucolipotoxicity. Further, loss of hnRNPK significantly reduced the interaction
between DDX3X and 18S. These findings suggest a model in which an hnRNPKDDX3X complex increases JUND translation in part via recruitment of the PIC.
To study translational regulation in the setting of β cell dysfunction, I employed
the models of PDX1 deficiency and glucolipotoxicity. While my data implicate the
PCBP family members as translational regulators in both of these models, the
mechanisms by which the PCBPs impact translation are likely distinct in these
two scenarios. For example, NKX2-2 exhibited increased translation during
PDX1 deficiency, but I did not detect any induction of NKX2-2 during
glucolipotoxicity. Furthermore, I did not observe any change in phosphorylation of
hnRNPK during PDX1 deficiency, unlike glucolipotoxicity.
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It is currently unclear how depletion of PDX1 affects the ribosome occupancy of
the poly(C)-containing mRNAs. One possibility is that PDX1 controls expression
of a component of the translation machinery that is not required for genes with
PCBP binding in their 3’UTR. For example, PDX1 deficiency causes a modest
reduction (~50%) in eIF1AX and eIF1AD, which have been implicated in PIC
recruitment and start codon selection (Passmore et al., 2007), similar to DDX3X
(Guenther et al., 2018). Therefore, one interesting possibility is that genes
regulated by an hnRNPK-DDX3X complex can “escape” translational repression
caused by reductions in eIF1AX/D. However, PDX1 regulates a very broad set of
genes in β cells, so there are many possible mechanisms that could explain
altered translation of the poly(C)-containing genes. Indeed, I have tested a
number of potential mechanisms based on genes regulated by PDX1 but have
been unable to establish a connection to the post-transcriptional regulation of
NKX2-2 or JUND. These mechanisms include: sequestration by a decoy RNA
(insulin or PDX1 mRNAs), competition with other RBPs (PTB or YBX1), loss of
eIF4H, and altered recruitment of BRG1 or the long-noncoding RNA NEAT1.
5.2 Additional screens for translational regulation in β cells
In the current work, I have used TRAP-seq to study translational regulation in
Min6 cells with PDX1 deficiency. This approach was successful in that it led to
the identification of JUND as a translationally regulated gene and suggested a
role for the PCBP family of RBPs in mediating this post-transcriptional regulation.
However, there are a number of additional screens one could imagine to further
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investigate translational regulation in β cells. Given the induction of JUND during
glucolipotoxicity, it would be interesting to determine how widespread
translatome remodeling is in this model. Alternatively, TRAP could be performed
in Min6 cells treated with conditions to invoke particular forms of stress, such as
thapsigargin/tunicamycin (ER stress) or hydrogen peroxide/nitric oxide
(oxidative/nitrosative stress). These treatment strategies may be favorable over
glucolipotoxicity as they would be focused on a particular stress response and
therefore be potentially less complex. For example, glucolipotoxicity may
simultaneously invoke a number of pathways in β cells, such as responses to ER
stress, oxidative stress, and mitochondrial dysfunction.
Beyond additional TRAP-seq studies, a very exciting extension of this work
would be to use ribosome profiling (or an adaptation of this method) to globally
assess start codon usage in β cells. Alternative translation initiation appears to
be widespread and can increase the diversity of proteins expressed in a cell
(Ingolia et al., 2011). Furthermore, start codon usage may be altered under
stress or disease conditions (Kearse and Wilusz, 2017; Sendoel et al., 2017).
However, mapping of start codon usage to identify alternative initiation sites
under stress conditions has not been performed in β cells. This is particularly
intriguing in the context of type 1 diabetes as it has been suggested that
translation of a non-canonical open reading frame in the insulin mRNA may
generate an immunogenic peptide contributing to disease onset (Kracht et al.,
2017). Thus, one can imagine the power of this approach to uncover novel
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mechanisms of translational regulation that may be altered under conditions
associated with diabetes.
Another promising extension of my work is the use of TRAP to assess
translational regulation during stress conditions in vivo, such as high fat diet
feeding. A mouse has been generated to express the GFP-RPL10A transgene in
a Cre-driven manner (Liu et al., 2014). Thus, the use of a β cell-specific Cre line
will allow for the purification of ribosome-bound mRNA specifically from β cells.
Limiting material may cause this application to be technically challenging,
however, the continued advancement of sequencing technologies suggest it will
likely be possible in the near future.
5.3 Assessment of RBP functions in β cells
The work presented here includes the first characterization of functional roles for
the PCBP family members in β cells. Importantly, I came upon this family of
RBPs through an unbiased search for regulatory motifs in our TRAP screen.
Using in vitro models, I have implicated the members hnRNPK and PCBP1/2 in
several aspects of β cell biology, including post-transcriptional control of gene
expression, maintenance of cell identity, and glucose-stimulated insulin
secretion. Thus, an important next step will be the use of mouse models to
genetically delete these factors in vivo, which is ongoing work in the Stoffers’
laboratory. To connect phenotypic findings to PCBP function, a number of
approaches will be required, including CLIP-seq and transcriptome/translatome
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assessments to identify pertinent target genes. Given the multifunctional nature
of these RBPs, they may have broad roles in β cells, however, a careful and
systematic analysis of their function holds great promise to uncover novel
aspects of β cell biology.
Furthermore, there is an extensive array of RBPs in the mammalian genome that
control all aspects RNA processing. However, we are only just beginning to
understand how this class of proteins may shape critical processes involved in β
cell biology. Thus, it will be important to undertake studies aimed at uncovering
novel roles for RBPs in β cells. In this work, I have accomplished this by using a
de novo motif analysis to narrow our focus on RBPs with specificity for cytosinerich sequences. Similarly, new screens for translationally regulated genes could
also be analyzed to search for enriched regulatory motifs. This bottom-up
approach will be strengthened by the increasing number of publically available
data sets to globally define RBP targets by eCLIP (Van Nostrand et al., 2016),
which will allow for the assessment of gene sets for enrichment of RBP binding,
not just motif frequency.
Alternatively, novel roles for RBPs in β cells could be identified by a top-down
approach, which would start with screening for RBPs with unique characteristics
in β cells. For example, transcriptomic, proteomic, or phospho-proteomic data
sets could be mined to identify RBPs with altered abundance or modifications in
conditions associated with diabetes. Similarly, relative expression could be
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assessed to identify RBPs with especially high expression levels in β cells
compared to other cell types. 	
  
5.4 Expanding the analysis of JUND function and regulation
In β cells, JUND regulates a cohort of genes implicated in redox imbalance and
inflammation, and these genes are commonly dysregulated in models of β cell
dysfunction. However, the extent to which each of these genes contributes to β
cell apoptosis is unknown. For example, NOS2, a nitric oxide synthase, has been
implicated in mediating β cell damage in the context of cytokine treatment
(Zumsteg et al., 2000). However, nitric oxide may play beneficial roles in β cells
under certain circumstances by neutralizing other oxidant types (Broniowska et
al., 2015). Thus, the induction of several pro-oxidant genes by JUND may lead to
complex downstream effects on redox homeostasis based on the types and
subcellular locations of the generated oxidants. While we believe it is unlikely that
the observed pro-apoptotic role for JUND can be entirely ascribed to one
particular target gene, close scrutiny of these genes may provide new insights
into redox imbalance during metabolic stress.
It should also be noted that the oxidative stress assay used in this work
(CellROX) is not specific to any particular oxidant, but rather detects a range of
ROS types. This was a useful approach to screen for general oxidative stress
levels; however, follow-up studies using more specific assays could provide
better insight into which oxidants are upregulated during glucolipotoxicity in a
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JUND-dependent manner. For example, dihydroethidium and spin trapping of
nitrogen dioxide can be used to specifically detect superoxide and nitric oxide
levels, respectively (Pace and Kalyanaraman, 1993; Zhao et al., 2003). These
analyses may also shed light on which JUND targets are contributing to oxidative
stress during glucolipotoxicity.
Besides its pro-oxidant role, JUND also regulates several pro-inflammatory
genes with connections to islet inflammation, including Ccl2, Cxcl1, and Cxcl2.
Interestingly, these genes have been linked to poor outcomes for islet
transplantation (Citro et al., 2012; Piemonti et al., 2002), suggesting that
modulation of JUND levels could be a novel approach to advance this clinically
relevant application. It is unlikely that the induction of these pro-inflammatory
genes contributed to the phenotypes observed in our in vitro and ex vivo systems
because their main function involves immune cell recruitment. Nevertheless, we
cannot rule out the possibility that these genes also have cell-autonomous roles
in β dysfunction. To better assess the relevance of the pro-inflammatory gene
signature, however, it will be important to investigate the benefit of JUND
depletion or MEK inhibition using in vivo islet transplantation models.
Given its impact on oxidative stress and apoptosis, the role of JUND in β cell
compensation during insulin resistance should also be studied. This will require
the generation of a conditional null allele for JUND. Crossing this mouse with a β
cell-specific Cre line will allow for the in vivo assessment of JUND function in β
cells. Based on our ex vivo work, we predict that loss of JUND would dampen
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oxidative stress in β cells during a high fat diet challenge, thus improving insulin
secretion and blood glucose homeostasis. However, it is possible that JUND also
regulates insulin secretion independent of its effect on oxidative stress and
apoptosis. Thus, a careful and thorough characterization of this in vivo model will
be required to assess the impact of JUND deletion on insulin secretion, oxidative
stress, cell survival, and proliferation during high fat feeding.
Similar to JUND depletion, I found a significant improvement in islet cell survival
during metabolic stress after treatment with the MEK inhibitor trametinib. The
application of this finding to in vivo models of diabetes is complicated by the fact
that trametinib treatment has been show to improve insulin resistance (Banks et
al., 2015). Thus, it will be impossible to discern whether any improvements in
insulin secretion or β cell viability seen with systemic trametinib administration
can be attributed to MEK inhibition in β cells or an indirect effect due to reduced
insulin demand. One approach to more specifically study the role of the
MEK/ERK signaling pathway in β cells in vivo would be to generate a mouse
model with a β cell-specific, inducible overexpression of a dominant negative
form of MEK1, which blocks ERK phosphorylation.
The connections between the PCBPs and JUND regulation include the presence
of a poly(C) stretch in the JUND 3’UTR, binding of the PCBP members to the
JUND mRNA, and loss of PCBPs leading to altered JUND steady-state protein
levels. Together, these findings suggest that the post-transcriptional regulation of
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JUND is directly mediated by the PCBPs via 3’UTR binding. To further support
this model, however, it would be pertinent to show that deletion of the JUND
poly(C) motif impairs its post-transcriptional regulation. A common approach to
address this question is to generate a reporter gene flanked by the JUND UTRs
containing deletions of putative regulatory elements, including the poly(C) motif.
Unfortunately, I have been unable to develop a model system to recapitulate the
induction of JUND during glucolipotoxicity despite many attempts, thus I could
not confidently assess the functionality of the poly(C) motif. Alternatively, genome
editing approaches could be used to delete the cytosine-rich sequence element
in the endogenous gene. It is unclear whether this would be feasible in Min6 cells
as it would require single cell cloning. On the other hand, a mouse model with
tissue-specific and inducible deletion of the JUND poly(C) motif could be used to
study whether loss of this sequence element abrogates JUND induction in
isolated islets treated with glucolipotoxicity. If so, it would be interesting to see if
this deletion also impacts β cell viability during in vivo stress conditions, such as
high fat feeding.
Lastly, I have established that JUND induction during metabolic stress is a
conserved process using isolated mouse and human islets. To extend these
findings to the pathogenesis of T2D in humans, it will be critical to evaluate JUND
levels in pancreatic tissue samples from diabetic patients. This analysis is
typically performed using immunofluorescence staining of pancreatic sections
from deceased organ donors. Our ability to perform this experiment is currently
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limited by the lack of an antibody to confidently detect JUND levels by staining.
Instead, we have relied on Western blot analyses to assess JUND abundance,
including for isolated islets from db/db mice. Similarly, we could compare JUND
levels in isolated islets from diabetic and non-diabetic human organ donors,
however, it is possible that the culturing period after islet isolation would provide
time for JUND levels to normalize between groups. Thus, it will be advisable to
optimize staining conditions for additional antibodies to determine if JUND levels
are altered in islets from diabetic individuals.
5.5 Translational regulation mediated by an hnRNPK-DDX3X complex
To expand our understanding of the factors regulating JUND translation in an
hnRNPK-dependent manner, I searched the hnRNPK interactome using publicly
available mass spectrometry data sets. Consistent with its highly multifunctional
nature, hnRNPK has a broad array of binding partners (Mikula et al., 2015). To
narrow my search, I capitalized on the fact that JUND is known to have a highly
structured 5’UTR that requires helicase activity for efficient translation (Hartman
et al., 2006), leading me to screen three helicase genes. Of these, I found that
only DDX3X was required for efficient translation of JUND in β cells. I propose a
model in which hnRNPK and DDX3X form a complex that recruits the translation
pre-initiation complex (PIC) to the JUND mRNA. Further experimentation will be
required to clarify several mechanistic details of this model.
First, it is currently unclear whether the hnRNPK-DDX3X complex regulates
translation in a cap-dependent manner. Several studies, along with my own data,
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indicate that there is a global suppression of translation in β cells during
glucolipotoxicity (Hatanaka et al., 2014). This is likely attributed both to the
phosphorylation of eIF2α and the induction of 4E-BP1 levels, which sequesters
eIF4E and reduces cap-dependent translation (Yamaguchi et al., 2008). Thus,
JUND may “escape” translational suppression during glucolipotoxicity via capindependent translation mediated by the hnRNPK-DDX3X complex. The relative
requirement for the 5’ cap in translation initiation is often assessed by inserting
5’UTR sequences into a bicistronic reporter assay. Given my challenges to
model JUND translation using reporter systems, however, it is unclear whether
this approach will be useful to assess cap-independent mechanisms.
One difference between the effect of hnRNPK and DDX3X on JUND translation
is that hnRNPK is only required for the induction of JUND during metabolic stress
but does not impact JUND regulation under baseline conditions. On the other
hand, loss of DDX3X impairs JUND translation both under baseline and stress
conditions. One possible explanation for this discrepancy is that DDX3X can
interact with an additional factor or factors under baseline conditions that can
functionally substitute for hnRNPK, and this unknown factor may be lost or
inactivated under stress conditions. For example, DDX3X interacts with PABP
(Soto-Rifo et al., 2012), which binds to the 3’UTR of the JUND mRNA via the
polyA tail. Thus, under baseline conditions, PABP and hnRNPK may play
redundant roles in JUND translation via their interactions with DDX3X. During
stress conditions, however, PABP may be inactivated or reduced, leading to the
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dependency on hnRNPK for efficient JUND translation. PABP can be regulated
by its expression level, proteolytic cleavage, post-translational modification, and
the expression of inhibitory factors, such as PAIP2 (McKinney et al., 2013; Walsh
et al., 2013). However, it is currently unknown if any change in PABP expression
or function occurs during glucolipotoxicity.
While I chose DDX3X as a candidate based on its known helicase function, it is
unclear whether this enzymatic activity of DDX3X is required for JUND
translation. Indeed, some DEAD-box proteins regulate translation of specific
mRNAs via recruitment of the PIC, which is independent of their helicase activity
(Marintchev, 2013). Thus, it will be worthwhile to mutate the functional domains
of DDX3X to further examine how this protein regulates JUND translation.
Additionally, DDX3X has been implicated in the proper selection of translation
initiation sites (Guenther et al., 2018). Interestingly, I have found that loss of
DDX3X in Min6 cells leads to the appearance of an additional faint band for
JUND on western blot, which may represent translation from an alternative start
codon. To expand on this observation, ribosome profiling could be used to
globally map translation initiation sites in control and DDX3X-depleted β cells.
Additionally, the precise mechanism by which hnRNPK may impact DDX3X
function deserves closer examination. I considered the possibility that hnRNPK
recruits DDX3X to the JUND mRNA in a stress-dependent manner, but I saw no
change in the hnRNPK-DDX3X interaction during glucolipotoxicity by coimmunoprecipitation experiments. Instead, I found that DDX3X interacts with the
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18S ribosomal RNA, a component of the PIC, in an hnRNPK- and stressdependent manner. However, it is unclear how hnRNPK regulates the interaction
between DDX3X and the PIC. To better understand the components of this
complex and how they change under metabolic stress, it would be informative to
perform mass spectrometry on hnRNPK- and DDX3X-interacting factors under
control and glucolipotoxic conditions.
I have implicated DDX3X in regulating JUND translation in β cells, but whether
this RNA helicase impacts β cell function or viability is unknown. DDX3X likely
regulates a range of targets in β cells, thus it is unclear whether loss of this factor
will have any overlapping phenotypes with those we have observed for JUND
depletion. Given its links to cell cycle progression, apoptosis, and innate
immunity in other cell types (Ariumi, 2014), however, a broader examination of
DDX3X function in β cells is warranted. Anecdotally, CRISPR-mediated depletion
of DDX3X in Min6 cells leads to a significant reduction in cell number over time.
This may be attributable to a reduction in cell proliferation as DDX3X has
previously been shown to enhance translation of the mRNA encoding cyclin E1
(Lai et al., 2010). To better define the role of DDX3X in β cells, loss-of-function
studies should be performed in primary islets or in vivo to assess the impact on
cell survival, proliferation, and insulin secretion. Furthermore, a broad
examination of genes regulated by DDX3X should be carried out using TRAPseq or ribosome profiling to provide mechanistic insight into how this RNA
helicase impacts β cell biology.
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